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Toxoplasma gondii is an obligate intracellular parasite that can infect a broad range of hosts, 
including mammals and birds. Felines, including wild and domestic cats, are the sole definitive 
hosts that can discharge millions of parasites into the environment through their feces in the form 
of oocysts. Due to the massive number of oocysts one cat can shed, and their highly infectious and 
resistant nature, the environmental contamination by oocysts poses a serious public health concern. 
Therefore, a better understanding of T. gondii transmission in the environment is essential. To this 
end, we compiled and analyzed genotypic data from animals in North America across a proximity 
gradient from human settlements to the wilderness (Chapter 2). We demonstrated that, T. gondii 
genotype distribution was associated with the spatial habitat and host species, and that parasite 
diversity decreased towards the human environment, suggesting the human impact on parasite 
transmission. To better understand the environmental contamination by oocysts, we developed a 
comprehensive protocol to evaluate the contamination by T. gondii on a typical farm in Tennessee 
(Chapter 3). T. gondii oocyst contamination in both soil and animals was detected on the farm. 
The results demonstrated that animals, especially meso-predators (such as raccoons and skunks), 
were good indicators of T. gondii prevalence in the environment. Thirdly, to reduce the 
environmental contamination, methods were tested to produce a potential cat vaccine in cell 
culture (Chapter 5). Lower temperature (31) was used to generate viable parasites of a vaccine 
strain (T263) in cell culture. Thus far, laboratory tests have lent evidence of the partial success. 
Lastly, we investigated 11 cases of fetal toxoplasmosis in captive macropods (kangaroos and 
wallabies) that occurred between 2014-2018 in the Busch Gardens Zoo, Florida (Chapter 4). 
Parasites were isolated and characterized using molecular methods. The results revealed over these 
three years, three independent infection events occurred at the zoo, suggesting frequent 
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Toxoplasma gondii is an obligate intracellular parasite that can infect a broad range of hosts. It has 
been more than 100 years since its discovery in 1908 in rodent in France and in rabbit in Brazil 
(Dubey, 2010). T. gondii belongs to Phylum Apicomplexa and genus Toxoplasma and is the only 
species in the genus (Dubey, 2010). The medical significance of T. gondii was not recognized until 
1939 when the parasite was found in the tissues of a congenitally-infected infant in New York, 
USA (Wolf et al., 1939). Likewise, its veterinary significance was not appreciated until it was 
found to be the culprit of abortion storms in sheep in Australia (Hartley and Marshall, 1957). One-
third of the global human population has been chronically infected (Dubey, 2010). Among 
individuals older than six years in the U.S., 13.2% have been infected in a cross-nation survey in 
2009 - 2010 (Jones et al., 2014). Infection in immunocompetent individuals generally induces no 
or mild symptoms. However, recent studies have reported acute infection in immunocompetent 
people, which demands intensive treatment. Toxoplasmosis can be life-threatening in immuno-
compromised individuals, such as HIV patients (Weiss et al., 2013). Likewise, in seronegative 
women, exposure to T. gondii during pregnancy can cause congenital toxoplasmosis, devastating 
the fetuses and neonates (Remington et al., 2006). 
Life Cycle    
The T. gondii life cycle was not revealed until 60 years after its discovery. In 1970, Frenkel, Dubey, 
and Miller unraveled its complex life cycle mystery (Frenkel et al., 1970). Felids, including the 
domestic cats (Felis domesticus), are the sole definitive hosts of T. gondii and thus play a pivotal 
role in its transmission (Hunter et al., 2012) (Figure 1.1).  
Like many protozoa, T. gondii switches between several distinct life stages in response to 
its environment. Three stages are observed in T. gondii. Being the fast-growing stage, tachyzoite 
propagates and disseminates rapidly in its host, which marks the acute infection. The bradyzoite 
is the semi-dormant stage in which the parasite replicates slowly in tissue cysts. The sporozoites, 
existing as oocysts, are the environmental form, which can be widely dispersed and are therefore 
responsible for the efficient and extensive transmission of the parasite.  




bradyzoites, and oocysts. Upon infection, the sexual reproduction occurs in the intestinal epithelial 
cells of the definitive hosts. Parasites excyst from tissue cysts or oocysts upon digestion by 
proteolytic enzymes in cat stomach. In the intestinal epithelial cells, tachyzoites sequentially 
develop into schizonts, merozoites, and gametes. Macrogametes are fertilized by microgametes to 
form diploid zygots which are enclosed by oocyst walls, released into the intestinal lumen, and 
ultimately excreted into the environment (Dubey, 2010). In most cases, a parasite can self-mate in 
cat epithelial cells; however, in rare cases, when a cat eats prey that contains more than one strain 
of T. gondii, a genetic cross can take place. Oocysts disseminate in the environment and 
contaminate environmental matrices such as water, vegetables, fruits, and soils. Ingesting oocysts 
accounts for the infection in intermediate hosts such as humans and livestock. Intermediate hosts 
can also contract infection via transplacental/vertical transmission or by eating meat containing 
tissue cysts. After a few days to months of acute infection, parasites retire into host tissues and 
become semi-dormant, which marks the onset of the chronic disease. Bradyzoites in the form of 
tissue cysts reside in host tissues, especially muscular and neural tissues, typically for the lifetime 
of the hosts. The life cycle of T. gondii is completed when the definitive hosts (felids) eat the 
parasites residing in the tissues of the intermediate hosts (Weiss and Kim, 2013).  
Two geographically separated life cycles are known to exist in T. gondii transmission, 
namely sylvatic and domestic life cycles. The two cycles have wild felids and domestic cats as 
definitive hosts, respectively (Shwab et al., 2018) (Figure 1.2). Before the rise of agriculture 
11,000 years ago, the sylvatic life cycles likely sustained T. gondii in the environment with wild 
felids being the definitive hosts and other wild mammals and birds being the intermediate hosts 
(Shwab et al., 2018). The prosperity of human society afforded by agriculture engendered the 
flourish of house mice and domestic cats, both of which formed close commensal relationships 
with humans. The stored grains from successful agriculture attracted mice, which in turn attracted 
cats (Rosenthal, 2009). Consequently, the success of human civilization and animal husbandry 
inadvertently established the domestic cycle of T. gondii. 
As human society continues to expand and prosper, humans slowly encroach upon the 
wildness. As a result, the boundary between the wild and domestic spheres became increasingly 
obscure. The dwindling interspace between the wild and the anthropized environment increased 




modern-day T. gondii transmission had featured an unprecedented overlapping of the two cycles 
(Pongsiri et al., 2009). Two major routes contribute to the transmission overlapping of the two life 
cycles, namely through the environmentally widespread oocysts or through carnivorism in which 
wild animals eat domestic animals and vice versa (Figure 1.2). Noteworthily, oocyst contamination 
of water due to soil runoff has been suggested to be the culprit of sea mammal infection (Sundar 
et al., 2008). The overlapping of two life cycles is clearly reflected in sea otter (VanWormer et al., 
2014) and coyote (Jiang et al., 2018), as the dominant genotypes in domestic and those in wild 
animals were found to co-dominate in these animals. 
Tachyzoites, Bradyzoites, and Oocysts 
Tachyzoite and bradyzoite  
A tachyzoite, a size of 2 × 6 µm, is crescent-shaped with a pointed anterior end and a rounded 
posterior end (Dubey et al., 2010). A tachyzoite has a centrally located nucleus and many 
organelles, including rhoptries, micronemes, amylopectins, dense granules, and apicoplasts 
(Figure 1.3). Although tachyzoites have no visible locomotive structures such as cilia, flagella or 
pseudopodia, it can slightly move its body, such as gliding, flexing or rotating. Tachyzoites can 
invade any nucleated mammalian cell. Host cell invasion is a process involving protein secrection 
and actin-based motility and is divided into seven steps in Figure 1.3. During the invasion, 
microneme (MI) secrete proteins to engage in host cell attachment and motility, whereas the 
rhoptry neck (RN) secreted a wide array of proteins (RONs) to form moving junction (MJ), and 
rhopty bulb secretes other proteins (ROPs) to modify parasitophorous vacuoles (PVs) and 
modulate host cell transcription (e.g., the phosphorylation of transcription factors by ROP16) 
(Figure 1.3).   
Once formed moving junction, the parasite invaginates the plasma membrane of host cell 
and finally enters host cell. Once inside, parasite is enclosed by a parasitophorous vacuole 
membrane (PVM) to sequester parasites from the host cytosol. In addition to not fusing with 
lysosomes or becoming acidic, the PVs also recruits host mitochondria and ER which may help 
parasite obtain nutrients. After a lag period, tachyzoites within PVs start to replicate asexually via 




cell. A rosette (8 or 16 parasites) is formed in the case of synchronous cell division. The burgeoning 
tachyzoites soon rupture the host cells and are ready for next round of invasion.  
Under the pressure of host immune system, especially the IFN- γ -dependent cell-mediated 
immune response, tachyzoites convert to bradyzoites six to seven days after infection (Dubey et 
al., 1998). Bradyzoite, a size of 1.5 ×7 µm, are enclosed by tissue cyst walls and become semi-
dormant. The cyst wall is formed through the protein modification of PVM, although the exact 
composition of the cyst wall is unclear. Being non-immunogenic, the cysts reside in host tissues, 
awaiting a chance for transmission. Without the active and systemic host immune defense, the in 
vitro formation of bradyzoite/cysts was different from that of in vivo in many perspectives. In cell 
culture, tachyzoite and bradyzoite can spontaneously interconvert (Bohne et al., 1993). However, 
the conversion of tachyzoites to bradyzoites is not a synchronized event in vitro as one vacuole 
can harbor parasites expressing tachyzoite-specific antigens and those expressing bradyzoite-
specific antigens (Gross et al., 1996).  
T. gondii cysts have a propensity for neural (central nervous system, the eyes) and muscular 
tissues (skeletal muscles, cardiac muscles), although a broad spectrum of visceral organs can 
harbor tissue cysts, including lung, liver, kidney, and bone marrow (Skariah et al., 2010). The size 
of the tissue cysts varies from 5 µm to 100 µm with varying number of bradyzoites enclosed. A 
tissue cyst can harbor as few as two bradyzoites in the case of a young tissue cyst and as many as 
thousands of bradyzoites in the case of an old tissue cyst. However, tissue cysts do occasionally 
rupture and release bradyzoites which can flourish and cause diseases in the case of immune 
suppression. The reactivation of bradyzoites is especially noteworthy in AIDS patients and cancer 
patients who undergo chemo and or radiation therapy (Weiss et al., 2013).   
The stage interconversion 
The interconversion between tachyzoites and bradyzoites is significant in chronic infection as well 
as disease reactivation. Understanding the molecular basis of the interconversion can aid in the 
identification of drug targets to clear bradyzoites in the chronic stage.  
Tachyzoites differ from bradyzoites in many perspectives (Dubey et al., 1998). Although 
both are crescent-shaped, tachyzoites are plump, while bradyzoites are slender. Ultrastructurally, 




granules, posteriorly located nuclei as opposed to centrally located nuclei. Bradyzoites are more 
resistant to pepsin or trypsin digestion. Furthermore, tachyzoite and bradyzoite express different 
cell surface proteins.  
A wide range of approaches have been employed for tachyzoite and bradyzoite 
interconversion in vitro. It has been known that tachyzoite to bradyzoite conversion is a stress-
related phenomenon. The high temperature at 43 ℃, high (8.0-8.2) or low (6.6-6.8) pH, chemical 
stress (i.e., Na arsenite) can result in the upregulation of bradyzoite-specific gene expression and 
the shutting down of tachyzoite-specific gene expression (Soete et al., 1994). Nitric oxide (NO), 
an inhibitor of mitochondrial function, was believed to be a potent differentiation inducer. IFN- γ 
triggered bradyzoite-specific surface protein expression was partially attributed to the downstream 
induction of NO (Bohne et al., 1994). Sodium nitroprusside, a NO donor, was capable of inducing 
tachyzoite to bradyzoite differentiation in vitro (Bohne et al., 1994). The in vitro produced 
bradyzoites proved to be pepsin resistant (Dubey et al., 1998; Popiel et al., 1996) and can orally 
infect both mice (Fux et al., 2007) and cats (Hoff et al., 1977). The conversion from bradyzoite to 
tachyzoite is triggered when the immunological factors (e.g., IFN- γ) or host immune defense, 
especially T cell response, is lacking (Lyons et al., 2002). Prolonged in vitro propagation has 
favored tachyzoite formation and decreased the efficiency of bradyzoite formation in some 
avirulent strains of T. gondii (Weiss and Kim, 2011). 
Tachyzoite and bradyzoite are antigenically distinct (Lyons et al., 2002), which can be 
utilized for stage identification. Concerning surface proteins, tachyzoite expresses unique proteins 
including SAG1/p30, SAG2A, and SAG2B, whereas bradyzoite expresses a different repertoire of 
antigens including SAG4/p18, BSR4/p36, BAG1/hsp30, SAG2C, and SAG2D. BAG1 (bradyzoite 
antigen 1) is homologous to a small heat shock protein in plants. BAG1 protein expression on the 
bradyzoite surface is an early event of differentiation and thus is widely used as a differentiation 
marker. Cells expressing BAG1 were seen after 24 hours of exposure to stress such as pH 
8.1(Weiss and Kim, 2011). Deletion of BAG1 did not prevent cyst formation but only hindered 
the efficiency of cyst formation (Bohne et al., 1998). Bradyzoites also express lactate 
dehydrogenase 2 (LDH2), enolase 1(ENO 1), and matrix antigen 1(MAG1). In contrast, 
tachyzoites express LDH1 and ENO2, and have no MAG1 expression. The formation of the cyst 




not on bradyzoite. A 116 kDa glycoprotein CST1 containing N-acetylgalactosamine on the cyst 
wall was capable of binding to Dolichos biflorus lectin (DBL). In addition, the cyst wall can also 
bind to succinylated wheat-germ agglutinin (S-WGA). Consequently, DBL or S-WGA can be used 
to detect cyst wall formation in mature cysts.  
The metabolism of bradyzoites and tachyzoites are also different. While both utilize 
glycolytic pathways to obtain energy, tachyzoite also utilizes tricarboxylic acid (TCA) cycle and 
respiratory chain, whereas bradyzoite lacks the TCA cycle and respiratory chain (Denton et al., 
1996). As a result, the enzymatic activity in each stage form is different. The activity of lactate 
dehydrogenase (LDH) and pyruvate kinase is higher in bradyzoite (Denton et al., 1996). 
Bradyzoite relies on breaking down amylopectin to lactate for energy and therefore resistant to 
acidic pH. Due to their metabolic differences, antibiotics interfering metabolism can also induce 
stage differentiation. Oligomycin, an inhibitor of mitochondrial ATP synthase, and antimycin A, 
an inhibitor of the electron transport chain, were shown to induce bradyzoite formation (Tomavo 
et al., 1995).  
Considering the nature of tachyzoites and bradyzoites, reducing growth rate in some strains 
can induce tachyzoite to bradyzoite conversion (Bohne et al., 1994). T. gondii strain differences 
were seen in the variations of cyst size, number, and the efficiency of cyst formation. Strains with 
a slower growth rate and less virulence are predisposed to produce cysts in vitro. Slow-growing 
and less virulent strains such as ME49 tend to have a higher rate of bradyzoite formation than 
virulent and fast-growing strains such as RH strain (Soete et al., 1994). Drugs (i.e., pyrimethamine) 
and cytokines (i.e., IFN- γ) that can reduce the growth rate of the parasite can induce tachyzoite to 
bradyzoite switch (Bohne et al., 1994).  
The signaling pathway and molecular mechanism of interconversion are unknown. 
However, as a stress-induced response, the common stress-related pathways in eukaryotes are 
implicated. Cyclic nucleotide kinase is believed to partly mediate this interconversion (Eaton et 
al., 2006). A study has determined that inhibition of cAMP-dependent kinase and cGMP-
dependent kinase reduced parasite replication and induced the differentiation (Eaton et al., 2006). 
Parasite-specific eukaryotic initiation factor-2 (eIF2) kinase was also implicated in the 
differentiation process (Sullivan et al., 2004). As protein chaperones and transcription regulators, 




conversion process. After induction at pH 8.1, T. gondii hsp70 was induced 3-4 folds more than 
that of at pH 7.1, consistent with results seen in other Apicomplexans (Weiss et al., 1998; Shiels 
et al., 1997). Likewise, inhibition of HSP synthesis using quercetin hindered in vitro bradyzoite 
development (Weiss et al., 1998).  
Oocyst 
Upon being discharged into the environment, an oocyst requires one to five days to sporulate to 
become mature. One oocyst contains two sporocysts each with four haploid sporozoites. 
Sporulated oocyst, a size of 11 to 13 µm in diameter, is enclosed by a five-layer oocyst wall (Dubey 
et al., 1998).  
As the environmental form of the parasite, oocysts possess important features which 
ensures parasite’s effective transmission. First, oocysts are large in number. The number of oocysts 
one cat can shed ranges from 3 to 810 million during a median shedding period of eight days 
(Dubey, 2010). In California, the annual average oocyst burden in soil ranges from 94 to 4671 
oocysts per square meter (Dabritz et al., 2007). Oocysts have been proved to be highly hardy and 
infectious. Oocysts can survive in the environment for a prolonged period. Outdoors (6℃-36℃), 
oocysts in cat feces had survived for 46 days when the feces were uncovered, for 334 days when 
they were covered (Dubey et al., 1998; Frenkel et al., 1975). Oocysts are also resistant to chemical 
inactivation, including sodium hypochlorite and ozone (Dubey, 2010). However, oocysts can be 
destroyed by desiccation, or high temperature (55℃ for 2 min or 60℃	for 1 min) (Dubey, 1998). 
It has been revealed that oocyst-induced infection is more severe than bradyzoite-induced infection 
(Dubey et al.,1988; Dubey et al., 1973; Dubey et al., 1997a and 1997b). Oocysts are more 
infectious than bradyzoite in intermediate hosts. One oocyst can potentially induce infection in a 
laboratory pig (Dubey et al., 1996) or mouse (Dubey, 2010). Recent studies demonstrated that 
oocysts caused 78% of congenital infections in North America (Boyer et al., 2011), and 43% in 
Southern Chile (Munoz-Zanzi et al., 2010). 
Infectivity of tachyzoite, bradyzoite, and oocyst 
Cats are more susceptible to bradyzoite infection as compared to tachyzoite or oocyst infection; 




the prepatent period (time from infection to shedding oocysts) varies (Dubey, 2010). The prepatent 
period is 3 to 10 days with bradyzoite, but ≥19 days with tachyzoite, and ≥18 days in case of oocyst 
(Dubey, 2010). Moreover, the dose of tachyzoite required for oocyst shedding in a cat is 
approximately 100 times higher than that of bradyzoite (Weiss et al., 2011). Oral infection of as 
few as one bradyzoite can induce oocyst shedding in 16.6% (3/18) of cats, whereas 1,000 
bradyzoites can only orally infect 50% (12/24) of mice (Dubey, 2001). One oocyst can cause 
disease in a mouse, whereas 100 oocysts could not induce oocyst shedding in a cat (Dubey, 2001 
and 2006a). T. gondii is adapted to be transmitted in cats via bradyzoites, whereas via oocysts in 
mice (Dubey, 2010).  
Population Genetics 
The genetic information of T. gondii strains from geographically distinct locations and a wide array 
of host species have been unveiled owing to the advanced molecular techniques. Microsatellite 
DNA analysis (Ajzenberg et al., 2002 and 2010), polymerase chain reaction-restriction fragment 
length polymorphism analysis (PCR-RFLP) (Howe and Sibley, 1995; Su et al., 2006 and 2010), 
and intron sequencing (Khan et al., 2007 and 2011) have been used to investigate the genetic 
variation of T. gondii. Among these methods, PCR-RFLP is the most commonly employed and 
has been used on thousands of T. gondii strains. Examining the PCR-RFLP data of 1457 samples 
collected worldwide, Shwab et al. (2014) summarized the population genetic structure of T. gondii 
on a global scale (Figure 1.4). Based on this article, the northern hemisphere is dominated by a 
few clonal genotypes, whereas the population structure of the southern hemisphere is a mosaic of 
numerous atypical genotypes without dominant genotypes (Figure 1.4). The details of this pattern 
are outlined below.  
The designation of T. gondii genotypes has been streamlined using ToxoDB PCR-RFLP 
nomenclature in which genotype is numbered based on the order of discovery (Shwab et al., 2014). 
Genotype #1, #2 and # 3 were found worldwide, which are also the dominant genotypes in Europe. 
In North America, genotype #1, #2, # 3, # 4 and #5 are prevalent. In Africa, the dominant genotypes 
are #2 and # 3. #9 and # 10 are prevalent in East Asia. No genotypes seemingly predominate in 




type II and type III are believed to dominate in domestic animals. It is unknown as to what factor(s) 
contribute to this genotype partition.  
T. gondii Infection in Humans and Animals 
Infection in humans 
T. gondii is evolutionarily successful, infecting virtually all warm-blooded animals. In addition to 
its expansive host range, T. gondii is geographically ubiquitous, having been found on every 
continent, including Antarctica (Dubey, 2010). Seroprevalence of the human population varies 
from as low as 4% in Korea and as high as 92% in Brazil (Dubey, 2010). In the period 1999-2004, 
US-born women 15-44 of age had lower seroprevalence (11%) than women of the same age group 
who are foreign-born (28.1%) (Jones et al., 2007). Infection is higher in Latin America than in 
North America and East Asia. Infection rates are lower in cold, dry or high latitude regions as 
compared to warm or low latitude areas (Dubey, 2010). It has been shown that infection prevalence 
is associated with cooking habit, hygiene, and frequency of soil contact (Stagno et al., 1980; Jones 
et al., 2008). Incidence at large is declining in the last few decades in many countries (Aspöck et 
al., 1992; Kortbeek et al., 2004). A serosurvey conducted in the U.S. revealed that the age-adjusted 
T. gondii prevalence of US-born persons 12-49 years old decreased from 14.1% in 1988-1994 to 
9% in 1999-2004 and 6.7% in 2009-2010 (Jones et al., 2014).  
Infection in immunocompetent people is generally asymptomatic. In some cases, mild 
symptoms, such as fever, malaise, and lymphadenopathy can develop. In rare cases, the infection 
causes severe ocular toxoplasmosis (e.g., retinochoroiditis), multi-visceral toxoplasmosis or even 
fatal outcomes. In the U.S., it has been estimated that 2% of the infections manifested as ocular 
toxoplasmosis; this number is 17.7% in southern Brazil (Holland, 2003). The underlying reasons 
for these severe cases in immunocompetent patients are elusive. Variabilities of host immunity, 
parasite strain, and other factors have been suspected to be relevant. It appears that these severe 
cases are often associated with highly virulent strains such as those found in South America 
(Carme et al., 2002; Demar et al., 2007). Over 50 cases of human toxoplasmosis had been reported 
in French Guiana since 1998; isolates from these patients were found to be atypical and highly 




to be the cause (Dardé et al., 1998; Carme et al., 2002; Demar et al., 2007). In Brazilian children, 
in addition to the higher occurrence, the severity of congenital ocular toxoplasmosis is also higher 
than that in Europe (Gilber et al., 2008). Two thirds of T. gondii isolated from citizens of the United 
States belong to type I (highly virulent) or atypical genotypes (Grigg et al., 2001).  
One of the recent research interests of T. gondii is linking T. gondii chronic infection with 
the tendency of patients to take risks (Johnson et al., 2018), tendency for accidents (Flegr et al., 
2002), behavior impairments (Sugden et al., 2016), and mental disorder (Brown et al., 2005). In 
immunocompromised patients, the reactivation of latent infection can be life-threatening. 
Encephalitis resulting from intracerebral focal lesion and or pneumonia are the hallmarks of 
toxoplasmosis in AIDS patients (Dubey et al., 1998). 
Infection during pregnancy in previously uninfected women can lead to congenital 
infection in fetus or neonates. The risk of congenital infection is lowest (10-15%) in the first 
trimester; however, the potential damage is the most severe if infected (Dubey and Jones, 2008). 
On the contrary, infection risk in the third trimester is the highest (60–90%), and the damage is 
less severe if infected (Dubey and Jones, 2008). The manifestation of congenital infection varies 
from spontaneous abortion, stillbirth to congenital disabilities in newborns (Remington et al., 
2006). Symptoms of congenital toxoplasmosis in neonates include hydrocephalus, microcephalus, 
cerebral calcification and retinochoroiditis (Remington et al., 2006). Some children may be healthy 
at birth but could develop visual or neurological sequels (e.g., learning disability) later in life 
(McLeod et al., 2006).   
Infection in animals associated with human households (cats, rodents, pigs, chickens, cattle, 
sheep, and goats) 
Cats 
As the definitive hosts, domestic cats are of utmost importance in the study of epidemiology and 
transmission of T. gondii. Studies showed that T. gondii infection is scarce or lacking in areas 
without cats (Dubey, 1997c; Munday et al., 1972; Wallace et al., 1969). Cats, historically used by 
humans to protect stored grains from rodents, have long ago formed a commensal relationship with 
humans dating back approximately 9,000 years (Driscoll et al., 2007). Today, one-third of 




cats and 73 million feral cats in the U.S. (Dubey, 2010).  
Cats are also common on farms. A 1999 study demonstrated that a mean of 8.5 cats was 
present on each pig farm in Illinois, of which six were seropositive for T. gondii (Weigel et al., 
1999). An average of 30% of cats worldwide has T. gondii antibodies, which suggests that they 
have already shed oocysts and can re-shed oocysts upon reinfection (Dubey, 2010). Cats, 
regardless of age, are capable of shedding oocysts. Most cats were believed only to shed oocysts 
for a week once in their lifetime, however; empirical data attested that cats could re-shed oocysts 
upon reinfection six years after the initial infection (Dubey, 1995). At any given time, 1% of cats 
were expected to shed oocysts (Dubey, 2010). Taking advantage of the clinical samples 
accumulated in an animal laboratory in the United States, a study showed that 31% of 12, 628 cats 
had T. gondii antibodies, which coincides with the estimated global seroprevalence (30%) in cats 
(Vollaire et al., 2005). Infection rates in cats can be much higher in other parts of the world. In 
southern Brazil where a water-associated outbreak of toxoplasmosis had occurred, 84.4% (49/58) 
of cats were seropositive for T. gondii (Dubey et al., 2004).  
Unlike many other animals, cats can suffer from clinical toxoplasmosis. Some individuals 
develop symptoms including lethargy, anorexia, or sudden death. Histological manifestations 
involve inflammation or necrosis in multiple organs including heart, brain, eyes, liver, and 
pancreas. At present, T. gondii isolates from domestic cats are scarce. Eight isolates were obtained 
from cats on pig farms in Illinois, among which five were type 12 (Dubey et al., 1995).  
Rodents 
A large-scale bioassay using tissues from 5,166 rodents across 17 species revealed that only a 
small proportion (0.9%) of rodents were infected with T. gondii (Hejlícek and Literák, 1998). 
Rodents can harbor T. gondii but may have no detectable antibodies in their blood. Viable parasites 
have been isolated from seronegative rodents (Dubey et al., 1995; Dubey et al., 1997d). Therefore, 
bioassay is the definitive method for T. gondii detection in rodents. Immunological tolerance and 
short lifespan of rodents are believed to account for the low infection rate in rodents. T. gondii 
susceptibility in rodents varies highly even in closely related species. It has been known that rats 
(genus Rattus) are resistant to T. gondii infection, whereas house mice (Mus musculus) are highly 





The prevalence of T. gondii in pigs varies. Feeder pigs and market pigs are typically raised indoors 
in well-managed facilities, and thus their seroprevalence is declining (Dubey et al., 1995). 
However, the seroprevalence of pigs raised in poorly managed or non-confined facilities is as high 
as 68% (Dubey et al., 2008). Noteworthy risk factors of pig infection include direct contact with 
oocysts and eating dead mice (Weigel et al., 1995b). Viable T. gondii has been frequently isolated 
from pork for human consumption; isolation rate ranges from 0.3% to 92.7%, depending on the 
age of pigs and pig farming conditions (Dubey and Jones, 2008).  
Chickens 
Chicken raised in the backyard are often infected with T. gondii with infection rates ranging from 
27% to 100% worldwide (Dubey and Jones, 2008; Dubey et al., 2005b; Dubey et al., 2006b). A 
study conducted in Paraná, Brazil revealed that 12.2% (47/386) of free-range chickens were 
seropositive for T. gondii; PCR-RFLP revealed ten different genotypes from 18 isolates, 
emblematic of the high genetic diversity in South America (Vieira et al., 2018). However, the 
infection rate is low in chickens raised in confined and industrialized feeding operations. T. gondii 
was not isolated from chicken breast meat, although T. gondii antibodies were found in the meat 
juice (Dubey et al., 2005a).  
Cattle 
Cattle are resistant to T. gondii infection. Although cattle can be infected with T. gondii oocysts, 
they can gradually clear parasite or reduce the infection to an undetectable level (Dubey and Jones, 
2008). The underlying mechanism of parasite resistance in cattle is elusive. In an experimental 
setting, 10,000 of oocysts were fed to each of the four steers weighing 100-150 kg; the fourth steer 
became seronegative after 15 months, and no parasite was isolated using the cat bioassay three 
years post infection (Dubey, 1992). Attempts to detect T. gondii antibodies using beef juice has 
been futile (Dubey et al., 2005a).  
Sheep and Goats 
Sheep and goats have been susceptible to T. gondii infection as evidenced by the frequent reports 




remain asymptomatic, which could be a source for human infection (Dubey and Kirkbride, 1989). 
Besides abortion and neonatal mortality, clinical signs of toxoplasmosis have been observed in 
adult goats (Dubey and Beattie, 1988), but not in adult sheep.  
Infection in wild (white-tailed deer, bobcats) or captive animals 
T. gondii infection has been steadily reported in wildlife. White-tailed deer and bobcats are among 
animals that are frequently sampled (Dubey et al., 2011). The infection in white-tailed deer heralds 
oocyst contamination in the wilderness because deer are strict herbivores. A recent study surveyed 
241serum samples from white-tailed deer in North America showed that 41.0% of these animals 
had T. gondii antibodies; 13 isolates were obtained with ten being ToxoDB genotype #5 (Gerhold 
et al., 2017). Infections in bobcats can be either through ingesting oocyst or through carnivorism. 
In one study, T. gondii antibodies were present in 51.7% of 58 bobcats from North America, 
Central America and South America (Kikuchi et al., 2004). In another study, parasites were 
isolated from 21 of 35 bobcat samples; the dominant genotype #5 (18/21) was revealed among 
these isolates (Verma et al., 2017).  
The infection in marine mammals indicates land-to-water oocyst contamination. Sea otter, 
sea lions, dolphins, and seals have been reported to have T. gondii associated encephalitis and T. 
gondii antibodies (Dubey et al., 2003). The sea otter was listed as a threatened species in the United 
States due to its dwindling population. T. gondii, capable of causing death in sea otter, had been 
suspected to be the principal culprit of sea otter’s decline. However, T. gondii and Sarcocystis 
neurona combined are responsible for the death of a small percentage (39/334=11.3%) of sea otter 
(Thomas et al., 2007). Seroprevalence in sea otter has been considered high, ranging from 47% to 
100% (Dubey and Jones, 2008). Sea otter seroprevalence is higher in California than in 
Washington. Bottlenose dolphins from both coasts of the United States have high T. gondii 
seropositivity (53%-100%), although not many isolates have been obtained (Dubey et al., 2003).  
Marsupials and New World primates are highly susceptible to T. gondii infection.  Acute 
toxoplasmosis has been reported in many species including squirrel monkeys (Saimiri sciureus) 
(Oh et al., 2018), ring-tailed lemurs (Lemur catta) (Juan-Sallés et al., 2011), marmoset (Saguinus 
imperator) (Epiphanio et al., 2000), woolly monkey (Lagothrix lagotricha) (Hessler et al., 1971), 




T. gondii has significant veterinary importance especially in zoos and theme parks. Acute 
and often fatal infection in captive kangaroos and wallabies was frequently reported worldwide 
(Basso et al., 2007; Boorman et al., 1977; Miller et al., 1992; Guthrie et al., 2017). As a result, 
zoos and theme parks had suffered from significant economic loss due to the death of expensive 
animals. Clinical signs of toxoplasmosis in macropods include blindness, weight loss, respiratory 
distress, diarrhea, neurological deficits, and sudden death. Necropsy and histological examination 
reveal hepatitis, inflammation, and necrosis in cardiac, skeletal, and smooth muscles (Portas, 
2010). Acutely infected macropods often succumb suddenly, and medicine treatment (e.g., 
sulfonamides and pyrimethamine, atovaquone) appears to be impotent to save lives (Portas, 2010). 
The Arms Race with Its Hosts 
T. gondii is an epitome of host-parasite coadaptation. The arms race between host defense and 
parasite virulence ensues as each imposes intense selective pressures on the other. Mice and cats 
are T. gondii’s natural and ancient hosts, whereas humans and many other intermediate hosts that 
are not part of natural feline’s food chain are considered as accidental hosts. As a result, the mice 
immune system is under prolonged selective pressures of the parasites, but not the human immune 
system– the very reason human lacks the immune defense mechanisms found in mice. The toll-
like receptor (TLRs) (TLR11, TLR12) and immunity-related GTPase (IRG) proteins are absent or 
nonfunctional in humans.  
Host immunity 
Among the host defense mechanism against parasite, Th1 cell-mediated immune response, namely 
the signaling pathway of IL12 – Th1– IFN- γ – intracellular killing, is the most significant (Figure 
1.5). In mice, endosomal TLR 7 and TLR 9 can recognize parasite RNA or DNA, whereas 
endosomal TLR11 and TLR12 recognize parasite profilin-like protein (PRF) (Gazzinelli et al., 
2014). Profilin is an essential protein of the parasite, governing parasite invasion and motility. The 
detection of profilin by a dendritic cell is a “detection at a distance” scheme. In addition to 
endosomal TLRs, cell surface TLR 2 and TLR 4 are also involved in the recognition of T. gondii. 
TLR 2 and TLR 4 can both be activated by T. gondii glycosylphosphatidylinositol (GPI), or T. 




receptors is likely marginal as compared to other toll-like receptors.  
Upon sensing the parasite, dendritic cells and monocytes are activated to produce IL-12, 
which triggers the production of IFN- γ mainly by NK cells, Th1 cells (Figure 1.5). The function 
of neutrophils in combating parasite includes the secretion of IL-12 and IFN- γ, phagocytosis, and 
the formation of extracellular DNA net (Bliss et al., 1999; Filisetti and Candolfi, 2004). Although 
neutrophils can produce reactive oxygen species, the role of ROS in parasite killing remains 
controversial (Murray and Teitelbaum, 1992). The production of IFN- γ in NK cells and T cells 
are IL-12 dependent, whereas the secretion of IFN- γ in neutrophils are regulated by TNF- α and 
IL-1ß. IFN- γ not only induces the production of proinflammatory mediators but also fosters the 
maturation of Th1 cells, which in turn enhance IFN- γ production. The IRG proteins produced in 
both myeloid cells and non-myeloid cells induced by IFN- γ are among the most effective 
parasiticidal effectors. In comparison to the conservative TLR 11 and TLR 12, IRG proteins are 
relative polymorphic, counteracting the mutative virulent factors of the parasite.  
In humans, the TLR11 gene contains three stop codons, which renders the gene unable to 
encode a functional protein. TLR12 is not present in the human genome. In the case of human 
immune defense, it is suspected that TLR7, TLR8, and TLR9 play similar roles in parasite 
recognition and subsequent activation of dendritic cells and monocytes (Gazzinelli et al., 2014). 
In addition, IRG proteins are missing in humans. It is intriguing and yet perplexing that TLR11, 
TLR12, and IRG proteins are absent in most mammals that T. gondii are capable of parasitizing. 
IFN- γ is a major effector in the killing of intracellular parasites through at least three 
mechanisms (Yarovinsky, 2014). First, IFN- γ induces the production of indoleamine 2, 3-
dioxygenase (IDO), which converts tryptophan to N-formylkynurenine, leading to tryptophan 
deprivation and parasite starvation. Another downstream effect of IFN- γ is the activation of nitric 
oxide synthase, which can release nitric oxide (NO). NO intermediates are nonpolar and uncharged 
which allow them to enter PVs to interact with parasites directly. NO modifies metabolic enzymes, 
rendering them nonfunctional. In addition, during the biosynthesis of NO, arginine is deprived due 
to the fact that L-arginine is a precursor of NO. T. gondii is an arginine auxotroph - the reason why 
arginine starvation can trigger tachyzoite to bradyzoite switch. Without arginine, the replication of 
the parasite is staunched. The third mechanism is through the induction of IRG proteins and p65 




are 22 members of IRG proteins in mice and only one in human (expressed in testes) (Howard et 
al., 2011). In human, the IRG homolog – IRGM is truncated and is not regulated by IFN- γ (Bekpen 
et al., 2005). It is unknown whether IRGM is participating in host defense against the parasite. The 
localization of IRGs onto PVs results in the disruption of PVs (Figure 1.6). Parasites are vulnerable 
once exposed to the cytosol and soon are disintegrated by lysosome (Figure 1.6). GBPs (seven 
GBPs in humans; 13 in mice) were believed to indirectly combat parasite by recruiting IRGs onto 
PVs (Selleck et al., 2013).  
In addition to Th1, CD8+ T cell is another component of the specific acquired immune 
response. Upon the activation by IL-2 (secreted by Th1), CD8+ T cells exert cytotoxic activity on 
infected cells or extracellular tachyzoites. The humoral immune response is also involved in the 
battle with the parasite. IgM appears in serum one week after infection, which is followed by IgG. 
IgG plays a critical role in maternal protection for the fetus as IgG can pass placenta. Antibodies 
play a role in killing extracellular tachyzoites through antibody-dependent cytotoxicity or 
opsonization.  
Parasite virulence  
T. gondii virulence has apparent strain variation in sensitive hosts (e.g., outbred mice) with type I 
being highly virulent (LD100=1), type II being intermediately virulent (LD50 ≥ 102 -104), and type 
III being avirulent (LD50 ≥105). The quantitative trait locus (QTL) mapping was used to identify 
virulence factors using progenies from sexual crosses among Type I, II, and III (Saeij et al., 2006; 
Taylor et al., 2006; Behnke et al., 2011). T. gondii strain virulence in mice seems to be 
geographically distinct. A recent study pinpoints that 61% of 427 isolates from Central and South 
America are highly virulent to house mice, whereas only 7% of 193 isolates from North America 
are virulent (Shwab et al., 2018). There is no apparent association between host species and T. 
gondii virulence. 
The polymorphic rhoptry-secreted kinase (ROPs) are first identified using forward genetics 
approach (Taylor et al., 2006, Saeij et al., 2006) as the significant virulent factors to counteract 
IRGs and GBPs. ROP18 is functional in Type I and II and not functional in type III due to the 
insertion in its promoter region (Boyle et al., 2008). ROP18 is capable of phosphorylating specific 




forward genetics approach, ROP5 was identified and was found to be indispensable to parasite 
resistance as highly virulent parasite completely lost virulence without ROP5 (Reese et al., 2011, 
Behnke et al., 2011). Despite being a pseudo-kinase, ROP5 forms a complex with ROP18 to 
facilitate the phosphorylation of IRGs (Figure 1.6) (Etheridge et al., 2014). ROP5 also complexes 
with ROP17 to target threonine residues of the IRGs (Figure 1.6) (Etheridge et al., 2014). ROP5 
is evolutionarily under intense selective pressure and thus being highly polymorphic. The 
interacting regions of ROP5 and IRGs are also their polymorphic sites, exemplifying the arms race 
between parasite and its host as each diversifies under selective pressure of the other. Similar to 
ROP18, the functionality of ROP5 varies in different strains: type I and III have a virulent form of 
ROP5, whereas ROP5 in type II is avirulent. ROP18 and ROP5 gene alleles combined can be used 
to predict T. gondii strain virulence in mice (Shwab et al., 2016).  
Dissertation Objectives 
Toxoplasma gondii is an inclusive parasite, inhabiting virtually all warm-blooded animals on every 
continent. Because of its undiscriminating host range and broad geographical distribution, we can 
use it as a model organism to study pathogen transmission and ecology in the context of human 
intervention on the environment. The recent few decades have witnessed an extensive genetic 
characterization of the parasite and thus enriched our understanding of parasite transmission and 
distribution on the planet. Studies of population genetics have unveiled an intricate and yet unique 
T. gondii genotype global landscape as a result of the evolutionary adaptation of the parasite to a 
wide array of distinctive environments. The northern hemisphere is dominated by a few clonal 
lineages, whereas numerous genotypes exists in South and Central America. Factors that shape the 
global genetic diversity of T. gondii has been addressed in a recent publication (Shwab et al., 
2018). According to the paper, the rise of agriculture 11,000 years ago and the concomitant 
flourishing of cat and mouse engendered the domestic life cycle of T. gondii. It was suspected that 
certain lineages of T. gondii were selected in the domestic life cycle and was expanded worldwide 
through agricultural expansion and human migration. In addition, a superinfection model was 
proposed to explain the virulence diversity in different continents. Alternatively, it has been 




the high diversity of T. gondii. Nonetheless, the cause of the contemporary T. gondii genetic 
structure is multifactorial.  
One of the primary implications of understanding transmission is to actively hamper the 
transmission to control parasite contamination in the environment. As cats are the ancestral and 
definitive hosts of T. gondii, it comes as no surprise that T. gondii infection is prevalent in cats, 
which indicates previous oocyst-shedding events and potential re-shedding upon reinfection. To 
make matters worse, the oocysts shed by cats are highly infectious and recalcitrant to disinfection. 
Given the number of domestic and feral cats in the United States and the number of oocysts each 
cat could shed, the environmental contamination by oocysts poses a threat to public health. The 
overarching goal of this dissertation is to understand T. gondii population genetics, its 
transmission, and ecology to develop control tactics to reduce its environmental contamination, 
thus alleviating the social-economic burden of this notorious parasite.  
Chapter 2 objectives 
To tackle the problem of environmental contamination, a better understanding of T. gondii 
transmission in the environment is fundamental. In recent decades, PCR-RFLP genotyping and 
microsatellite have considerably advanced the genetic characterization of T. gondii. With the 
accretion of genetically characterized strains of T. gondii, the population genetics of T. gondii has 
been steadily revealed, which aids in a better understanding of parasite transmission. Previous 
studies have indicated that North American T. gondii population is clonal and dominated by four 
archetypal lineages identified as types I, II, III, and type 12, Furthermore, type 12 is mainly found 
in wildlife; type II and III are mainly found in domestic animals (Dubey et al., 2011b). Factors that 
shape the genetic structure of T. gondii in North America are elusive. To tease them apart, we 
compiled and analyzed existing genotypic data from animals across a proximity gradient from the 
anthropized environment to the wilderness in North America. We aimed to investigate the effect 
of host habitat and host species on T. gondii transmission. We asked the following questions: 
• What are the genotype compositions of T. gondii in animal populations with different 
proximities to anthropized environment? How are these genotype compositions different? 




• Does T. gondii genotype distribution have host specificity? 
Chapter 3 objectives 
To control T. gondii enviormental contamination, we proposed that sandboxes can be used to 
reduce the environmental contamination by T. gondii. The hypothesis was inspired by the 
defecation behavior of cats who prefer loose sand to defecate to bury their feces (Turner and 
Bateson, 2000). The hypothesis was also supported by empirical data in which feral cats frequently 
used sandboxes (whether experimental set up in parks or those in school playground) to defecate 
(Lass et al., 2009; Uga et al., 1995 and 1996). To test that hypothesis, a typical dairy farm in East 
Tennessee was chosen as research site. It was planned that the farm contamination would be 
evaluated which would be compared to that of two years after sandbox implementation. As the 
project progressed, the initial idea of using the sandboxes to reduce environmental contamination 
was abandoned due to the low contamination of the farm by T. gondii. However, a systemic 
evaluation method was developed to assess the environmental contamination by T. gondii using 
animal infection in conjunction with soil oocyst detection. In this study, we sought to answer the 
following questions: 
• Are oocysts detectable in soil on a typical dairy farm harboring cats? Can we use oocyst 
contamination as an indicator of farm contamination? 
• How prevalent is T. gondii in domestic and wild animals appearing on the farm? Can we 
use animal infection rate to assess farm contamination? 
Chapter 4 objectives 
Captive macropods have suffered from fatal toxoplasmosis worldwide (Basso et al., 2007; 
Fernández-Aguilar et al., 2013; Guthrie et al., 2017). Recent reports of fatal toxoplasmosis in 
captive macropods in the United States have accentuated the significance of T. gondii infection in 
these animals and shed light on the urgency of developing control measures to reduce T. gondii 
contamination in zoological settings. Toxoplasmosis in this setting is noteworthy as theme 
parks/zoos suffer from myriad economic loss due to the death of expensive animals. Furthermore, 




for human infection. In this chapter, we attempted to isolate and characterize T. gondii from six 
cases of fatal toxoplasmosis from macropods in a theme park in Tampa, Florida. We sought to 
investigate the genetic features of the causative agent to understand the infection source of these 
fatal cases. We attempted to address the following questions: 
• Are T. gondii antibodies and viable parasite present in macropod sera and tissues, 
respectively?  
• What are the genetic characteristics of these T. gondii isolates? Could the genetic 
characteristics aid in the understanding of infection source? 
Chapter 5 objectives 
Attempts have been made to use vaccines to reduce T. gondii infection. However, these efforts 
have had limited success thus far. A live cystless strain (S48) of tachyzoite has been used in sheep 
to reduce neonatal mortality in Europe and New Zealand (Buxton et al., 1993). A vaccine for 
human use is not yet available as killed strains provide at best marginal protection and attenuated 
or mutant strains pose the risk of infection especially to fetuses (Dubey, 2010). The most effective 
vaccination strategy is in favor of the immunization of definitive hosts. A 3-year field trial revealed 
that vaccination of cats on eight commercial farms using T263 provided promise to reduce the 
infection in farm animals (finishing pigs and mice) (Mateus-Pinilla et al., 1999). However, the 
application of this cat vaccine is stalled due to several factors. The key problems are the exacting 
requirement for storage of tissue cysts produced in mice and the cumbersome procedures for 
preparation, which render the high price of the vaccine and result in the lack of interest of cat 
owners. In the conventional vaccine production, a mutant strain, T263, is injected into mice. Brain 
tissue is harvested, homogenized, digested with pepsin, and preserved in liquid nitrogen. Because 
parasites cannot survive long at room temperature, immediate administration to cats is required 
upon thawing of the vaccine for no more than 15 mins (Frenkel et al., 1991). 
 To simplify the vaccine production and to reduce its price, we sought to develop a 
methodology to produce live bradyzoites in vitro. To accomplish this, developing a way to convert 




temperature to induce the conversion from tachyzoite to bradyzoite. In this chapter, we aimed to 
answer the following questions: 
• Are vacuum conditions capable of inducing tachyzoite to bradyzoite conversion? 
• Is low temperature (31℃) capable of inducing tachyzoite to bradyzoite conversion? 
To help address the above questions, we used three criteria to distinguish between 
bradyzoites and tachyzoites and to assess the quality of treated tachyzoites under vacuum 
conditions or low temperature. We asked the following questions: 
• Do treated tachyzoites express BAG1 proteins and form cyst wall? 
• Are	treated tachyzoites more resistant to pepsin digestion? 
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Toxoplasma gondii counts among the most consequential food-borne parasites, and although the 
parasite occurs in a wide range of wild and domesticated animals, farms may constitute a specific 
and important locus of transmission. If so, parasites in animals that inhabit agricultural habitats 
might be suspected of harboring genetically distinct parasite types. To better understand habitat 
effects pertinent to this parasite’s transmission, we compiled and analyzed existing genotypic data 
of 623 samples from animals across a proximity gradient from areas of human settlement to the 
wilderness in North America. To facilitate such analysis, T. gondii isolates were divided into three 
groups: (i) from farm-bound animals (with the most limited home ranges on farms); (ii) from free-
roaming animals (with wider home ranges on or near farms); and (iii) from wildlife. In addition, 
parasite genotype distribution in different animal species was analyzed. We observed no absolute 
limitation of any of five major genotypes to any one habitat; however, the frequency of four 
genotypes decreased across the gradient from the farm-bound group, to the free-roaming group, 
then the wildlife, whereas a fifth genotype increased along that gradient. Genetic diversity was 
greater in free-roaming than in farm-bound animals. The genotypic composition of parasites in 
wildlife differed from those in farm-bound and free-roaming animals. Furthermore, parasite 
genotypes differed among host species. We conclude that T. gondii genotype distributions are 
influenced by the spatial habitat and host species composition, and parasite diversity decreases 
towards areas of human settlement, elucidating facts which may influence transmission dynamics 













The ubiquity of certain pathogens can reveal important differences in their local transmission 
dynamics. Habitat effects may be important in structuring the dynamics of transmission, and these 
differences may be epidemiologically consequential. Global analyses, and certain regional studies, 
have suggested that farming has disseminated a peculiar and especially consequential transmission 
dynamic, overlapping with (but qualitatively distinct from) conditions that prevail among wildlife 
hosts (Crosby, 2004; Rosenthal, 2009; Cincotta and Gorenflo, 2011). Toxoplasma gondii, the agent 
of human toxoplasmosis, has an extraordinarily broad intermediate host range, and is found in 
every habitat inhabited by its definitive feline hosts; but differences among habitats (and the 
composition of potential hosts) may significantly alter which parasites predominate (Mercier et 
al., 2011). Here, we sought to apply decades of molecular characterization in order to discern the 
extent and quality of differences among regions and hosts of this widespread parasite.  
Toxoplasma gondii is a successful apicomplexan parasite that infects a broad spectrum of 
hosts including mammals and birds. It is estimated that, on average, one-third of the global human 
population is infected (Dubey, 2010; Weiss and Kim, 2013). In 12–49-year-old US born 
individuals, 6.7% have been exposed to T. gondii (Jones et al., 2014). Infection can be life-
threatening in immunocompromised individuals such as HIV patients and those undergoing 
chemotherapy or radiation. Similarly, in pregnant women who have not been previously exposed 
to the parasite, infection during gestation can lead to congenital toxoplasmosis, which occurs in 
approximately 30–40% of babies born of infected mothers (Dubey, 2010). Manifestations of 
congenital toxoplasmosis vary from spontaneous abortion and stillbirth to ocular and cerebral 
damage to the infants. Infection in immunocompetent people generally causes mild symptoms 
such as fatigue and malaise, followed by chronic infection in which the parasite resides in host 
tissues and becomes semi-dormant. However, in rare cases, severe diseases may occur which 
require hospitalization or intensive health care (Demar et al., 2007; Elbez-Rubinstein et al., 2009). 
The cause of these severe cases is unclear, but they are most likely due to infection by highly 
virulent strains identified in South America (Ajzenberg et al., 2004; Demar et al., 2007; Elbez-




Beside humans, a wide variety of animals are infected by T. gondii, ranging from terrestrial 
and marine mammals to birds. As its sole definitive host, felids (domestic and wild cats) can shed 
millions of oocysts in their faeces and thereby contaminate the environment. Intermediate hosts, 
including humans and animals, become infected via accidentally ingesting oocysts disseminated 
in environmental matrices such as soil, water, fruit and vegetables. Upon infection, parasites reside 
in the form of tissue cysts in the muscular or neural tissues of the intermediate hosts. Toxoplasma 
gondii can be transmitted horizontally or vertically. In the case of horizontal transmission, 
bradyzoites in tissues or oocysts in the environment are ingested by intermediate hosts or definitive 
hosts. Vertically, parasites in pregnant hosts can pass through the placenta and can thus be 
transmitted to the foetus (Dubey, 2010). 
Toxoplasma gondii is genetically diverse among animal populations globally (Shwab et al., 
2014). Genetic diversity of this parasite is low in Europe and high in South America, with the 
diversity in North America being intermediate. There are a few lineages of T. gondii dominant in 
North America (Dubey et al., 2011b; Khan et al., 2011; Shwab et al., 2014). ToxoDB genotypes 
#4 and #5 (collectively known as type 12) are the dominant genotypes in wildlife in North America 
(Dubey et al., 2011b), while genotypes #1 and #3 (collectively known as type II) are often 
identified in domestic animals (Dubey et al., 2008b; Velmurugan et al., 2009). However, a 
comparison of genetic profiles of T. gondii in animal populations with differing degrees of human 
association has not, to our knowledge, been conducted. Here we have compiled and analyzed 
genetic data of T. gondii isolated from domestic and wild animals in North America. We have 
categorized T. gondii populations into three groups based on spatial distribution of animal hosts, 
and by animal species. We show a stratified distribution of genotypes along the spatial gradient 
from areas of human settlement to the wild. In addition, there is an association of T. gondii 
genotypes with animal host species, and parasite diversity decreases towards an area of human 





Materials and Methods 
Data collection 
Genotyping data of 623 T. gondii samples from animals in the USA and Canada were collected 
from published reports (Table 2.1). All samples were originally characterized using 10 multilocus 
PCR-RFLP markers (Su et al., 2010; Shwab et al., 2014). The 623 T. gondii samples were 
classified as having derived from farm-bound animals (n = 195), free-roaming animals (n = 135), 
or wildlife (n = 293). 
The farm-bound group included pigs (Sus domesticus), chickens (Gallus gallus 
domesticus), geese (Anser anser domesticus), house mice (Mus musculus) and domestic cats (Felis 
catus). These samples were collected from six US states including Illinois, Maryland, Iowa, 
Pennsylvania, Massachusetts and New Jersey (Table 2.1). Among the 195 samples, 168 pig 
isolates were collected from more than eight farms across six states: 85 were from Iowa (Dubey et 
al., 1995a; Mondragon et al., 1998; Velmurugan et al., 2009), 29 from Pennsylvania (Velmurugan 
et al., 2009), 53 from Massachusetts (Dubey et al., 2002, 2005; Velmurugan et al., 2009), and one 
from New Jersey (Dubey et al., 2005; Velmurugan et al., 2009). The remaining 27 samples were 
obtained from domestic animals including 11 chickens (Dubey et al., 2007b), nine domestic cats 
(Dubey et al., 1995b; Dubey and Prowell, 2012), six house mice (Dubey et al., 1995b) and one 
goose (Dubey et al., 2007b). These animals were either raised on pig farms or raised as pets (Dubey 
et al., 1995b, 2007b). For data analysis, the farm-bound animal group captures all animals that 
have limited home ranges on farms; they are not necessarily physically penned.  
The free-roaming animal group included goats (Capra aegagrus hircus), sheep (Ovis 
aries), alpacas (Vicugna pacos), feral cats (Felis catus), organic pigs (Sus domesticus) and free-
range chickens (Table 2.1). Given feral cats have larger home ranges and are likely to be away 
from farms, we assigned them to this group for data analysis. From the 135 samples, two were 
collected from Canada and the rest were collected from nine states in USA including Maryland, 
Virginia, West Virginia, Pennsylvania, Ohio, Michigan, Massachusetts and Texas. Fifty-five of 
these samples originated from sheep in a slaughterhouse in Baltimore, Maryland. These sheep 
were between 6 and 12 months old and were raised in small flocks in Maryland, Virginia and West 




2014a). One T. gondii strain was isolated from a congenitally infected lamb during a lambing 
season in Texas, USA (Edwards and Dubey, 2013). Twenty-nine T. gondii strains were collected 
from goat meat sold in retail stores in Maryland. These goats were raised in small flocks in 
Maryland, Virginia or Pennsylvania (Dubey et al., 2011a). Additionally, 22 chicken isolates were 
from free-range chickens from Ohio and Massachusetts (Ying et al., 2017). Nineteen isolates were 
obtained from organic pigs which were free roaming on the farms. Among these isolates, 15 were 
from Michigan from two organic pig farms where pigs were raised according to organic standards 
(Dubey et al., 2012); four were from Maryland, USA from a poorly managed farm in which pigs 
with poor nutritional diets scavenged on the premises (Dubey et al., 2008a). Four T. gondii isolates 
were obtained from feral cats with two from Canada (Dubey et al., 2008b), and two from 
Pennsylvania (Dubey et al., 2015). Additionally, two T. gondii isolates were collected from alpacas 
grazing on a pasture in Virginia (Dubey et al., 2014a).  
Of the 293 T. gondii isolates from wildlife, 288 were collected from 23 states in the USA 
and five samples from Canada (Table 2.1). The host animals from which parasites were 
successfully isolated and genotyped included 54 white-tailed deer (Odocoileus virginianus), 46 
sea otters (Enhydra lutris), 30 grey wolves (Canis lupus), 27 bobcats (Lynx rufus), 21 coyotes 
(Canis latrans), 13 black bears (Ursus americanus), 13 red foxes (Vulpes vulpes), 12 raccoons 
(Procyon lotor), 11 Canadian geese (Branta canadensis), and 24 additional wildlife species from 
which 66 strains were obtained (Table 2.1).  
Fourteen host species contained the requisite 10 or more T. gondii samples for inclusion in 
the species analysis. These include pigs, chickens, cats, Canada geese, sheep, goats, red foxes, 
black bears, raccoons, white-tailed deer, coyotes, bobcats, sea otters and wolves (Table 2.2). 
Eleven chicken isolates from a farm in Illinois were counted as one isolate due to an outbreak of 
toxoplasmosis among these chickens, and all 11 isolates belonged to the same genotype (#1) 
(Dubey et al., 2007b). This sample together with the other 22 isolates from free-range chickens in 
Ohio and Massachusetts were used as a population (Ying et al., 2017). The pig population 
comprised 168 isolates from the farm-bound animals and 19 organic pig isolates from the free-
roaming group. The cat population comprised nine isolates from farm-bound group and four feral 





The frequency of genotypes in each population was represented in pie charts constructed using 
GraphPad Prism (GraphPad Software, San Diego, CA, USA). Multilocus PCR-RFLP typing data 
was coded for all genetic loci. For a given locus, the presence or absence of DNA restriction 
fragments was coded with 1 s and 0 s, respectively. Therefore, a given locus was coded with a 
string of 1 s and 0 s. The genetic differences between and within populations was compared using 
Arlequin ver 3.5.1.2 (Excoffier and Lischer, 2010; Rajendran et al., 2012). For analysis with 
Arlequin, the data type was set as ‘‘haplotypic” data, and the data form was set as ‘‘Standard” 
which compares the data for their content at each locus without taking into special consideration 
the mode of mutation of the alleles. Within-population genetic diversity was determined at the 
haplotype level for each population. A between-population pairwise comparison was performed 
by genetic structure analysis, with the statistical significance level established by 1000 
permutations, and P = 0.001 was used as the statistical significance level. 
Results 
The spatial distribution of T. gondii genotypes 
The spatial distribution of T. gondii genotypes is summarized in Fig. 2.1. For the farm-bound 
animal group, seven genotypes were identified among the 195 T. gondii samples. ToxoDB 
genotypes #1 and #3 (collectively known as type II) and #2 (type III) were the major genotypes 
accounting for 56.4% (110/195) and 25.6% (50/195) of the total, respectively. Genotypes #4 and 
#5 (collectively known as type 12) accounted for 12.3% (24/195) and 0.5% (1/195), respectively. 
In addition, genotype #8 accounted for 4.6% (9/195), and #42 for 0.5% (1/195).  
For the free-roaming animal group, 25 genotypes were identified from 135 T. gondii 
samples. Genotypes #1, #2, #3, #4 and #5 accounted for 32.6% (44/135), 20.7% (28/135), 11.1% 
(15/135), 8.9% (12/135) and 3.0% (4/135) of the samples, respectively. The remainders of the 
isolates were represented by 20 atypical genotypes accounting for 23.7% (32/135) of the total (Fig. 
2.1).  
Within the wildlife group of 293 T. gondii samples, a total of 38 genotypes were identified 




(28/293), 8.9% (26/293), 5.1% (15/293) and 43.7% (128/293) of the samples, respectively. The 
remaining isolates were represented by 33 genotypes, each of which accounted for a small 
proportion of the total. Collectively, these accounted for 21.1% (62/293) of samples in the group 
(Fig. 2.1).  
Within-population diversity and pairwise comparison of genetic makeup of the three spatial 
groups was performed using Arlequin v. 3.5.1.2. Within-population diversities for farm-bound 
animals, free-roaming animals and wildlife were relatively high in each case (0.75 ± 0.01, 0.83 ± 
0.02, and 0.78 ± 0.02, respectively) (Table 2.1). A pairwise comparison of genetic makeup showed 
that T. gondii in the wildlife population was significantly different from that in the farm-bound 
and free-roaming animal populations (P < 0.001) (Table 2.1). There was no significant difference 
between farm-bound and free-roaming animal populations. In addition, there were 1, 11 and 23 
unique genotypes for farm-bound, free-roaming and wildlife populations, respectively. 
Toxoplasma gondii genotype distribution in animal species 
The genotypic composition of each animal population with 10 or more isolates is shown in Table 
2.2. Within-population genetic diversity of samples in bobcats (0.21 ± 0.10), wolves (0.31 ± 0.11), 
sea otters (0.65 ± 0.05) and white-tailed deer (0.70 ± 0.07) encompassed notably low diversity. 
However, between-population comparisons found these animal populations to be significantly 
different from at least five other animal populations (Fig. 2.2). In particular, parasites from sea 
otters significantly differed from those infecting 11 other species. Domestic animals (pigs, cats, 
chickens, sheep, goats) had similar genotypic compositions, whereas wild animals tended to have 
diverse populations. Genotype #5 dominated in a few wildlife species such as white-tailed deer, 
coyotes, bobcats, sea otters and wolves (Fig. 2.2). 
Discussion 
We have compared the composition of T. gondii genotypes in animals with varying proximities to 
areas of human settlement. There are several important findings. First, we found genotypes #1– #5 
in all three habitats. Genotypes #1 and #2 dominated farm-bound and free-roaming animal groups, 
while genotype #5 dominated wildlife (Fig. 2.1, Table 2.1). The frequencies of #1, #2, #3 and #4 




#5 increases along the same gradient. These results indicate a spatial partitioning of T. gondii 
genotypes across the habitat. Second, the within-population diversity in the free-roaming animals 
was similar to that in wildlife, but significantly higher than that of the farm-bound animals (Fig. 
2.1, Table 2.1), suggesting a lower genetic diversity of T. gondii in areas of human settlement than 
in the wild. Third, comparison of between-population genetic compositions showed that the 
wildlife group is significantly different from the farm-bound and the free-roaming groups (Fig. 
2.1, Table 2.1), and there were increasing numbers of unique genotypes along the gradient from 
farm-bound, to free-roaming, then to wildlife, suggesting different T. gondii genotypes are 
circulating in different spatial habitats. Finally, genotypes of T. gondii were associated with animal 
species (Fig. 2.2, Table 2.2). Farm animals (pigs, chickens, cats, sheep and goats) tended to harbor 
similar T. gondii genotypes, with genotypes #1, #2, and #3 being the major ones. However, parasite 
genotypes were more diverse in wildlife, with a clear dominance of genotype #5 in a few wildlife 
species including white-tailed deer, coyotes, sea otters and wolves.  
The low genetic diversity of T. gondii in areas of human settlement may be the result of a 
reduced biological diversity of animal hosts. Intensive animal rearing results in a reduction of local 
animal diversity and a dramatic increase in animal numbers, which in turn leads to a reduced 
diversity of animal pathogens and influences their transmission dynamic (Crosby, 2004; 
Mcdonalda et al. (2008); Pongsiri et al., 2009; Rosenthal 2009; Cincotta and Gorenflo, 2011). 
Under this uniform selective pressure, a small number of parasite strains with increased fitness 
would be expected to circulate in the population and to become dominant (Khan et al., 2014). In 
our analysis, 56.4% of the genotypes identified from animal species with close human association 
belong to the genotypes #1 and #3 (collectively known as type II), which suggests a selective 
advantage for these genotypes within the domestic animal population. Given that these genotypes 
also predominate in Europe, they may have established themselves in North America through 
maritime animal transportation, especially in well-adapted hosts such as domestic cats and rodents 
(Lehmann et al., 2006). The flourishing of agriculture and intensive animal farming may then have 
facilitated their spread in the domestic population. Notably, these two genotypes were also found 
in free-roaming animal populations and wild animals, accounting for 45.1% and 24.6% of 




domestic animals to wild animals. Alternatively, these genotypes may enjoy especially efficient 
transmission on farms.  
In contrast to the agricultural environment, natural ecosystems such as forests support a 
much greater biodiversity, including a high diversity of both hosts and pathogens. Consistent with 
this trend, we showed that T. gondii genetic diversity is higher in wildlife species. Thirty-eight 
genotypes were observed wild animals (more than five times the number observed in a sample of 
nearly 10 times as many domesticated hosts). However, these 38 genotypes identified from wild 
animals were not equally represented (Fig. 2.2). Genotype #5 dominated in a few wild animal 
species, whereas #1, #2 and #3 dominated in domestic animals. It is particularly interesting that 
bobcats have a limited diversity of T. gondii genotypes; #5 is overly dominant in this definitive 
host. This result is in agreement with a previous study in which wild felids were 14 times more 
likely to be infected with #5 (Type X) than feral domestic cats, and animals in less developed 
landscapes were more likely be infected with #5 than developed landscape (VanWormer et al., 
2014). Taken together, it suggests a potential fitness advantage of particular genotypes in domestic 
and wild animals, respectively. This phenomenon also lends support to the idea of distinct, 
geographically separated domestic and sylvatic transmission cycles. Notably, the sea otter 
population is extraordinarily unique (Fig. 2.2) as its genotypes comprised of approximately equal 
numbers of #5 (n = 24), and #1 and #3 (type II, n = 18). This suggests that the genotypic 
composition of sea otters may have two overlapping transmission cycles (VanWormer et al., 
2014).  
We grouped domestic animals with wider home ranges into an independent group (free-
roaming). These animals included goats, sheep and feral cats. From this group, 135 isolates were 
collected, among which 25 different genotypes were identified. Parasites isolated from these 
animals showed a higher diversity compared with those from the farm-bound group (seven 
genotypes). Genotypes #1, #2, #3 and #4 were found to be the major genotypes in this group of 
animals, which is most likely the result of the overlapping phenomenon of the domestic and 
sylvatic transmission cycles. Moreover, the other genotypes found in this group are mostly 
different from those identified in wild animals, which suggests genotypic specificity in different 




group, the genetic profile of this population may be incomplete. More isolates of this group from 
a wider geographic region will be needed to draw firm conclusions.  
In addition to the geographical location from which parasites were isolated, our findings 
suggest that host animal species may shape the genetic structure of T. gondii populations in North 
America. Strong genetic differences characterized populations derived from various host species, 
perhaps owing to some degree of species-specific host adaptation. However, regional sampling 
biases may contribute to the appearance of such differences. Thus, the degree to which each of 
these two factors contributes to the genetic structure of T. gondii in North America remains 
unclear. To more precisely define these contributions, future studies should examine the genetic 
structure of sympatric parasites isolated from different host species, and others should examine a 
given host species across its geographic range.  
Host-specificity of T. gondii genotypes may have ramifications for human infection. The 
eighty-four sheep and goat samples intended for human consumption, obtained from retail meat 
stores or slaughterhouses, yielded twenty-four genotypes of T. gondii. This high level of diversity, 
coupled with the established potential for parasite transmission to humans from these hosts, raises 
concerns about the potential for the transmission, from ovine samples, of atypical parasite lineages 
that may include especially virulent types. Future studies focusing on surveillance of parasite 
infections in goats and sheep would not only help identify T. gondii strains present in the 
environment but would also shed light on parasite-to-human transmission routes.  
Taken together, our findings demonstrate an inverse relationship between parasite diversity 
and the proximity of host habitat to areas of human settlement, indicating the dramatic impact of 
human modification of habitat on the distribution of T. gondii strains in the environment. The 
prevalence of genotype #5 strains in wild hosts suggests that they may have originated in wild 
animals and have successfully circulated in the wilderness. However, difficulties in isolating 
parasites from asymptomatic, chronically infected animals cloud our understanding of the true 
prevalence and genotypic composition in many host species. For example, pigs contribute 
disproportionately to our current description of genetic diversity in domestic animals. In contrast, 
isolates from domestic cats, the definitive host that is the core of the domestic cycle, are scarce in 
our study. A previous study showed that, due to its large population size, domestic feral cats 




likely played a more important role in transmission of T. gondii in domestic animals and humans 
(VanWormer et al., 2013). Further study focusing on T. gondii strains from domestic cats and a 
broader host spectrum from more geographically diverse regions is imperative. These data 
underscore the impact of host proximity to human society on parasite population structure. A 
greater understanding of this relationship may be achieved through increased sampling from a 
greater diversity of host species and geographic areas and should provide invaluable insights into 
the dynamics of the transmission of T. gondii and potentially other important zoonotic human 
pathogens. 
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Chapter 2 Appendix 
Table 2. 1 Toxoplasma gondii isolates from animals in different environments and geographical locations in North America 
Spatial 
groups 














Pigs (n=168), chickens 
(n=11), cats (n=9), house 





Maryland (n=1), New 
Jersey (n=1) 
#1 (n=70), #2 (n=50), 
#3 (n= 40), #4 (n=24), 
#5 (n=1), #8 (n=9), 
#42 (n=1). Total: 7 
genotypes 
#42 0.75 +/- 









Dubey et al. 
(1995a, b, 2002, 
2005, 2007b), 
Dubey and Prowell 
(2012), 
Mondragon et al. 
(1998), 





Sheep (n=59), goats 
(n=29), free-range 
chickens (n=22), organic 
pigs (n=19), feral cats 
(n=4), alpacas (n=2) 
Maryland, Virginia and 
West Virginia (n=55), 
Maryland, Virginia and 
Pennsylvania (n=29), 
Ohio (n=15), Michigan 
(n=15), Massachusetts 




(n=2), Texas (n=1) 
#1 (n=44), #2 (n=28), 
#3 (n=15), #4 (n=12), 
#5 (n=4), #7 (n=4), #9 
(n=1), #32 (n=1), #39 
(n=3), #54 (n=1), #72 
(n=1), #73 (n=2), #74 
(n=1), #110 (n=1), 
#113(n=1), #118 
(n=1), #130 (n=1), 
#131 (n=1), #143 
(n=1), 
#154 (n=1), #156 
(n=1), #167 (n=1), 
#170 (n=5), #216 
(n=2), #230 (n=2). 
Total: 25 genotypes 
























Dubey et al. 
(2008a,b,c, 2011a, 
2012, 2014a, 
2015),  Edwards, et 







Table 2.1 Continued 
Spatial 
groups 














(n=54), sea otters 
(n=46), wolves (n=30), 
bobcats (n=27), coyotes 
(n=21), red foxes (n=13), 
Canadian geese (n=11), 
black bears (n=13), 
raccoons (n=12), 
dolphins (n=7), hawks 
(n=7), Bennett's 
wallabies (n=6), arctic 
foxes (n=5), geese (n=4), 
wallabies (n=4), 
skunks (n=4), swans 
(n=3), 
feral pigs (n=3), white-
footed mice (n=2), 
Hawaiian crows (n=2), 
moose (n=2), badgers 
(n=2), opossums (n=2), 
mouflon sheep (n=2), 
bald eagles (n=2), elks 
(n=2), brown bear (n=1), 
woodrat (n=1), cougar 
(n=1), European starling 
(n=1), barn owl (n=1), 








South Carolina (n=15), 
Maryland (n=12), 
Alaska (n=10), 
Georgia (n=9), New 
Jersey (n=9), Hawaii 










(Canada) (n=1), Ohio 
(n=4), Massachusetts 
(n=3), North Carolina 
(n=3), Michigan (n=2), 
Texas (n=2), 
Washington D.C. 
(n=1), Rhode Island 
(n=1) 
#1 (n=34), #2 (n=28), 
#3 (n=26), #4 (n=15), 
#5 (n=128), #7 (n=3), 
#8 (n=1), #9 (n=1), 
#10 (n=1),  #11 (n=1), 
#14 (n=1), #15 (n=2), 
#24 (n=2),  #32 (n=2), 
#39 (n=2), #54 (n=2), 
#66 (n=1), #90 (n=1), 
#141 (n=1), #143 
(n=1), #146 (n=1), 
#147 (n=1), #154 
(n=1), #157 (n=1), 
#167 (n=3), #177 
(n=2), #180 (n=1), 
#186 (n=1), #216 
(n=11), #219 (n=1), 
#220 (n=1), #221 
(n=3), #249 (n=1), 
#261 (n=3), #262 
(n=1), #263 (n=6), 
#266 (n=1), #267 
(n=1). 
Total: 38 genotypes 
#10, 11, 14, 




















Howe and Sibley 
(1995), Dubey et 
al. (2007a, 2008b, 
2009, 2010, 2011b, 
2013a, b, c, 2014b, 
c, 2015, 2017), 
Sundar et al. 
(2008), Yu et al. 
(2013), Verma et 
al. (2015, 2016 a,b, 
2017), Guthrie et 
al. (2017), Gerhold 
et al. ( 2017) 
C.I., Confidence interval. 
a Locations are states of the USA except where otherwise indicated in parentheses. 




   roaming animals is significantly higher than the farm-bound animals, P < 0.05.  





Table 2. 2 Toxoplasma gondii populations of 14 animal species from North America. 






#1 (n=67), #2 (n=53), #3 
(n=36), #4 (n=17), #5 (n=1), 
#7 (n=3), #8 (n=8), #42 (n=1), 
#113 (n=1). 




Michigan (n=15), Maryland 
(n=4), New Jersey (n=1), 
0.75 +/- 0.02, 
95% C.I. (0.72, 
0.78) 
Dubey et al. (1995a, 2002, 
2005, 2008a, 2012); 
Mondragon et al. (1998), 





#1 (n=8), #2 (n=11), #3 (n=1), 
#170 (n=3). 
Total: 4 Genotypes 
Ohio (n=15), Massachusetts 
(n=7), Illinois (n=1) 
0.66 +/- 0.06, 
95% C.I. (0.54, 
0.78) 
Dubey et al. (2007b), Ying 




#1 (n=1), #3 (n=1), #4 (n=6), 
#5 (n=1), #8 (n=1), #130 
(n=1), #216 (n=2). 
Total: 7 Genotypes 
Illinois (n=8), Pennsylvania 
(n=2), Manitoba (Canada) 
(n=2), Maryland (n=1) 
0.79 +/- 0.11, 
95% C.I. (0.58, 
1.01) 
Dubey et al. (2008b, 2015), 





#1 (n=1), #2 (n=5), #4 (n=2), 
#143 (n=1), #266 (n=1), #267 




0.80 +/- 0.11, 
95% C.I. (0.58, 
1.02) 
Dubey et al. (2014c), 




#1 (n=17), #2 (n=9), #3 (n=9), 
#4 (n=9), #5 (n=1), #7 (n=1), 
#9 (n=1), #32 (n=1), #39 
(n=2), #72 (n=1), #73 (n=2), 
#74 (n=1), #54 (n=1), #110 
(n=1), #131 (n=1), #230 
(n=2). Total: 16 Genotypes 
Maryland, Virginia and 
West Virginia (n=55), 
Virginia (n=3), Texas (n=1) 
0.86 +/- 0.03, 
95% C.I. (0.80, 
0.91) 
Dubey et al. (2008c,2014a), 







Table 2.2 Continued 




aegagrus hircus)  
n=29 
#1 (n=9), #2 (n=4), #3 (n=4), 
#4 (n=3), #5 (n=2), #39 (n=1), 
#118 (n=1), #143 (n=1), #154 
(n=1), #156 (n=1), #167 
(n=1), #170 (n=1). Total: 12 
Genotypes 
Maryland, Virginia and 
Pennsylvania (n=29) 
0.87 +/- 0.04, 
95% C.I. (0.79, 
0.96) 




#1 (n=1), #2 (n=2), #3 (n=3), 
#4 (n=1), #54 (n=1), #141 




0.87 +/- 0.07, 
95% C.I. (0.74, 
1.00) 





#1 (n=3), #2 (n=2), #4 (n=2), 
#5 (n=2), #90 (n=1), #147 
(n=1), #216 (n=2).  Total: 7 
Genotypes 
Pennsylvania (n=8), 
Maryland (n=3), Alaska 
(n=1), Quebec (Canada) 
(n=1) 
0.91 +/- 0.05, 
95% C.I. (0.82, 
1.01) 
Dubey et al. (2008b, 2010, 




#1(n=2), #2 (n=1), #4 (n=1), 
#5 (n=4), #7 (n=2), #32 (n=2).  
Total: 6 Genotypes 
Wisconsin (n=5), Georgia 
(n=3), Minnesota (n=2), 
Manitoba (Canada) (n=1), 
Texas (n=1) 
0.86 +/- 0.07, 
95% C.I. (0.72, 
1.00) 
Dubey et al. (2007a, 






#1 (n=2), #2 (n=4), #3 (n=4), 
#4 (n=4), #5 (n=29), #146 
(n=1), #154 (n=1), #167 
(n=1), #216 (n=4), #220 
(n=1), #221(n=3).  
Total: 11 Genotypes 
Mississippi (n=19), South 
Carolina (n=9), New Jersey 
(n=9), Pennsylvania (n=7), 
Ohio (n=4), Tennessee 
(n=4), Alabama (n=1), 
Minnesota (n=1) 
0.70 +/- 0.07, 
95% C.I. (0.57, 
0.83) 
Dubey et al. (2011b, 2013c, 
2014b,c ), Yu et al. (2013), 
Gerhold et al. (2017) 
Coyotes (Canis 
latrans) n=21 
#1 (n=7), #3 (n=2), #4 (n=4), 
#5 (n=7), #14 (n=1).  
Total: 5 Genotypes 
Pennsylvania (n=10), 
Wisconsin (n=7), Tennessee 
(n=2), Georgia (n=1), 
Minnesota (n=1) 
0.77 +/- 0.05, 
95% C.I. (0.67, 
0.87) 
Dubey et al. (2007a, 
2014c), Verma et al. 





Table 2.2 Continued 






#2 (n=1), #5 (n=24), #24 
(n=2). 
Total: 3 Genotypes 
Mississippi (n=20), Georgia 
(n=4), Alabama (n=2), 
Pennsylvania (n=1) 
0.21 +/- 0.10, 
95% C.I. (0.01, 
0.41) 
Yu et al. (2013), Dubey et 





#1 (n=6), #3 (n=12), #4 (n=1), 
#5 (n=24), #39 (n=2), #54 
(n=1). Total: 6 Genotypes 
California (n=29), 
Washington (n=17) 
0.65 +/- 0.05, 
95% C.I. (0.55, 
0.76) 
Howe and Sibley (1995), 
Sundar et al. (2008), Dubey 




#1 (n=2), #3 (n=1), #5 (n=25), 
#9 (n=1), #219 (n=1).  
Total: 5 Genotypes 
Minnesota (n=28), Alaska 
(n=1), Wisconsin (n=1) 
0.31 +/- 0.11, 
95% C.I. (0.10, 
0.52) 
Dubey et al. (2011b, 2013a) 
C.I., confidence interval. 







Figure 2. 1 Toxoplasma gondii genotype distribution along the spatial gradient from farm to the wild. The cartoon illustrates the 
spatial gradient and animal populations with varied proximities to human habitat. Representatives of animal species in each population 
are depicted. The numbers around pie chart edges indicate ToxoDB PCR-RFLP genotypes. The archetypal lineages (Type II, III, 12) 
are overlaid on pie charts in bold lettering. The sizes of pie charts correlate with the total number (and percentage) of isolates; colors of 





Figure 2. 2 Pairwise comparison of 14 Toxoplasma gondii populations for different host species. The number of each species is 
indicated in parentheses and the colors in the pie chart represent different genotypes. The between population comparison was conducted 
using Arlequin ver 3.5.1.2. The cut-off value for statistical significance was P=0.001. The “+” sign indicates significant difference 
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The environmental contamination by Toxoplasma gondii contributes to infection in humans and 
animals. However, T. gondii environmental contamination is largely uninvestigated due to the lack 
of a comprehensive evaluation system. In this study, a systemic evaluation method of T. gondii 
environmental contamination was developed by examining soil oocyst contamination in 
combination with wild and domestic animal infection on a farm. The study was conducted on a 
typical dairy farm in East Tennessee from May 2016 to April 2017. Twenty-two soil samples were 
collected from two cat habitats on the farm. Oocysts in the soil were sucrose-floated and subjected 
to DNA extraction and PCR-RFLP. Three (13.6%) samples were PCR-RFLP positive; however, 
T. gondii DNA was not consistently detected from these three samples on repeat testing. Rodents 
and mesopredators were trapped on the farm with blood and or tissue samples obtained. 
Serological tests via Modified Agglutination Test revealed that at a cutoff of 1:25, 18.5% (5/27) 
of house mice, 40% (2/5) of white-footed mice, 70.6% (12/17) of raccoons and 50% (1/2) of farm 
cats, were seropositive for T. gondii antibodies; no antibodies were found in one brown rat, six 
cotton rats, one mole, sixteen opossums, and two skunks. Twenty-nine tissues samples from 
rodents were also collected and subjected to PCR detection. T. gondii was not found in any of the 
tissues of twenty-nine rodents via PCR-RFLP; however, one house mouse was positive for 
Hammondia hammondi and another house mouse for Sarcocystis spp. Sera from thirty heifers from 
the same farm were seronegative using MAT. In summary, soil sample oocyst contamination may 
be not sensitive to determine T. gondii contamination, considering the low oocyst concentration in 
soil due to the significant dilution of oocysts by soil. Further, our results indicated that meso-
predators such as raccoons and cats are better indicators of T. gondii infection. 
 







Toxoplasma gondii is a coccidian parasite that has a broad spectrum of hosts, including humans, 
mammals, and birds (Dubey, 2010). T. gondii chronically infects one-third of the global human 
population and 6.7% of U.S. born individuals 12 to 49 years old (Jones et al., 2014). Seronegative 
pregnant women are susceptible to T. gondii infection, creating a significant public health threat 
due to the potential devastation to the fetus (Dubey, 2010). A fetal infection has a broad spectrum 
of ramifications, including stillbirth, spontaneous abortion, and various congenital disabilities in 
newborns (Dubey, 2010). There are an estimated 400-4000 cases of congenital toxoplasmosis each 
year in the U.S. (Jones et al., 2001). Life-threating outcomes are seen in individuals with 
compromised immune systems including HIV or cancer patients (Dubey, 2010). In immune-
competent people, infection generally consists of mild symptoms, such as fatigue or malaise; 
however, infection can result in intensive hospitalization despite the competent immune system of 
these patients. More serious cases likely result from infection with highly virulent strains of T. 
gondii (Dardé et al., 1998).   
T. gondii uses felids as definitive hosts. The central role of cats in T. gondii transmission 
was validated as there was no or less T. gondii infection in areas without cats (Wallace, 1969). 
Upon infection, felines, such as free-roaming domestic cats, shed millions of oocysts into the 
environment (Dubey, 2010). These oocysts can be dispersed into environmental matrices including 
water, vegetables, soil, and fruits. Intermediate hosts, such as humans and livestock, contract 
infection via inadvertently ingesting oocysts disseminated in the environment.  
As a companion animal of humans, the cat population increased with the growth of the 
economy and human society. There are approximately 78 million domestic cats and 73 million 
feral cats in the U.S. (Dubey, 2010). An average of 30% of cats worldwide is seropositive for T. 
gondii, indicating a current or previous shedding of oocysts and a potential re-shedding upon 
reinfection (Dubey, 2010). The number of oocysts one cat can shed ranges from 3 to 810 million 
over the shedding period of approximately one week. In California, the annual average oocyst 
burden in soil ranges from 94 to 4671 oocysts per square meter (Dabritz et al., 2007). Aside from 
their abundance, oocysts are hardy and resistant. Outdoors (6℃-36℃), oocysts can survive for 46 




3-9 cm in soil (Dubey, 1998; Frenkel et al., 1975). The concentration of the disinfectants used to 
sterilize drinking water such as sodium hypochlorite and ozone are unable to kill oocysts. High 
infectivity is another attribute of oocysts, which, further, perpetuates the transmission of the 
parasite. One oocyst alone can experimentally infect a pig (Dubey et al., 1996) or a mouse (Dubey, 
2006).  
The stability, high infectivity, and abundance of oocyst contribute to the successful 
transmission of T. gondii, posing a threat to the public health. Inadvertently ingesting oocysts is 
the primary source of human infection of T. gondii (Jones and Dubey, 2010). Severe clinical 
toxoplasmosis outbreaks have been associated with ingesting oocysts in drinking water or food 
(Bowie et al., 1997; De Moura et al., 2006). Oocysts have been identified as being responsible for 
78% of congenital infections in North America (Boyer et al., 2011). Oocysts in the soil can be 
washed off from terrestrial environments into large water bodies, leading to the infection of marine 
animals. T. gondii infection in aquatic mammals in California and the Amazon river signified 
oocyst contamination of water (VanWormer et al., 2014).  
The surveillance of T. gondii contamination in the environment is critical to assess the 
infection risks in both humans and animals. T. gondii infection in farm animals raised for human 
consumption poses a risk for human infection on account of human consumption of undercooked 
meat. The soaring demand for meat products from organically raised animals increased the odds 
of human infection (Weigel et al., 1999). Recent studies have shown that the non-confinement 
raised pigs have a higher rate of T. gondii infection (Dubey et al., 2012; Guo et al., 2016). The 
evaluation of T. gondii environmental contamination is fundamental for the development of 
methods to reduce the contamination. Controlling T. gondii environmental contamination is of 
great importance to reduce human infection, thus alleviating the social and economic burden of 
toxoplasmosis. To this end, it is imperative to establish a practical procedure to monitor T. gondii 




Materials and Methods 
Sample collection 
The twenty-two soil samples were collected from a dairy farm (Figure 3.1A)- the Little River 
Animal and Environmental Unit. The farm was located in Walland, Tennessee on 529 acres of 
land. The farm is affiliated with the University of Tennessee and was mainly used for research and 
education purposes. With a primary emphasis on milk and Holstein cow production, this farm is a 
representation of the modern dairy farm. There were roughly eight feral cats on the farm according 
to the farmers, which were kept for rodent control. The cats were fed by the farmers and had the 
freedom to hunt. Twenty-two soil samples were collected from the farm in May 2016 (Figure 
3.1B). Two locations were chosen for soil sample collection where cats were fed, resting, or seen 
free-roaming (Figure 3.2A). The first location (N 35° 46.005’; W 083° 50.455’) was the calf raising 
area where cats were fed and resting (Figure 3.2A, location # 1); The second location (N 35° 
46.142’; W 083° 50.546’) was the maintenance shop and silage storage area, where cats were 
found free-roaming (Figure 3.2A, location # 2). In each location, soil sampling sites were 
intentionally chosen to greatly disperse over a large area and to represent different vegetative 
cover. At each site, surface soil with a depth of no more than 2 cm in an area of 10 cm by 10 cm 
was collected in bags. Approximately 20 g of soil from each site was collected and stored at 4℃ 
before processing. 
Sugar floating method for oocyst extraction 
Sugar floating method was used to float oocysts in soil (Figure 3.2B) (Lelu et al., 2011). First, soil 
samples were dried and passed through a sieve with a mesh size of 2 × 2 mm at room temperature. 
For each sieved soil sample, 5 grams or 10 grams were taken for testing. In a 50 ml tube, 5 g of 
soil was mixed with 5 ml of 2% sulfuric acid. The mixture was then incubated at 4℃ overnight 
and diluted with 15 ml ddH2O the following day. In a new 50 ml tube, 20 ml cold sucrose solution 
(cane sugar; density: 1.20) was overlaid with the soil sample, which was subsequently centrifuged 
at 1500 × g for 20 min. The aqueous phase (approximately 10 ml) and interphase (approximately 




concentrate in the solution after centrifugation. The content was washed and finally suspended in 
100 µl ddH2O.  
PCR-RFLP for oocyst detection 
The concentrated oocysts were subjected to three cycles of freeze (-80℃) and thaw (+20℃) with 
no fewer than 4 hours at each temperature. DNA was extracted from the oocyst lysates using 
NucleoSpin soil DNA extraction kit (Macherey-Nagel, Duren, Germany; Cat: #740780.50). PCR-
RFLP targeting 18S ribosomal RNA (18S rRNA) gene was used for T. gondii detection using 
extracted DNA (Silva et al., 2009). This PCR-RFLP method was able to differentiate T. gondii 
from other closely related apicomplexans (Hammondia hammondi, Neospora caninum, 
Sarcocystis spp) without sequencing. The 25 µM external primers Tg18s48F/Tg18s 359R and 50 
µM the internal primers Tg18s 58F/Tg18s 348R were used for nested PCR amplification (Silva et 
al., 2009). The PCR product was 290 base pairs in the case of Sarcocystis neurona, N. caninum, 
T. gondii, and H. hammondi; a 310 base pair product was generated in the case of other Sarcocystis 
spp. Restriction enzymes Ddel, Hpy188III, and MspI were used to digest PCR products to 
differentiate among T. gondii, H. hammondi, N. caninum and Sarcocystis spp. Positive controls 
included in our study were DNA from T. gondii (PTG strain) cell lysates, extracted DNA from H. 
hammondi oocysts, and DNA from N. caninum cell lysates. 
The same PCR-RFLP method was used to detect T. gondii in tissues of twenty-nine trapped 
rodents. Five grams of tissues from brain and heart of trapped rodents were combined and 
homogenized. DNA was extracted from 100 µl of homogenized tissue (100 grams) using DNeasy 
Blood & Tissue Kit (Qiagen, Cat. No. 69504) and eluted in 100 µl AE buffer. 
The efficiency of oocyst detection from soil  
To test the sensitivity of the sugar floating method, H. hammondi oocysts (105 or 106) stored in 
our lab were spiked into 5 grams of T. gondii-negative soil. H. hammondi was used as a substitute 
for T. gondii due to its inability to infect humans and its close relation to T. gondii genetically 
(Silva et al., 2009). The spiked soil samples were subjected to the same procedure as mentioned 




Animal trapping and the detection of T. gondii infection  
Animals on the farm were trapped to investigate the prevalence of T. gondii infections. Two 
periods of trapping were conducted from September 2016 to April 2017 (Figure 3.3). During the 
first trapping period from September 2016 to November 2016, only rodents were trapped. The 
second trapping period from December 2016 to April 2017, both rodents and meso-predators were 
trapped; however, rodent trapping was terminated after March 5th, 2017 due to low seroprevalence 
in rodents. Animal trapping and handling were conducted in compliance with the procedures 
approved by the Institutional Animal Care and Use Committee (IACUC). Sherman traps (50-90) 
and Tomahawk traps (10) were used to trap small rodents and meso-predators, respectively. Traps 
were set at dusk and checked before dawn. Oatmeal was used as rodent bait, whereas sardine was 
used as bait for meso-predator trapping. For rodent anesthesia, cotton balls soaked with isoflurane 
were placed in traps. Rodents were then euthanized by heart injection of pentobarbital (Fatal-Plus 
Solution, 390mg/mL) at a dose of 3.9 mg per gram of rodent body weight. Animal carcasses were 
kept on ice and immediately transferred to the laboratory. Approximately 100 µl of blood sample 
was collected from each rodent. Heart and brain tissues were also collected from each rodent. 
Meso-predators were sedated using Ketamine (100mg/ml) and Xylazine (20mg/ml) at doses of 16 
mg/kg and 3.2 mg/kg per kilogram of animal body weight, respectively. The weight of the animal, 
pulse per min, breathing per min, and rectal temperature were recorded for each captured meso-
predator. No more than 8% of animal total blood volume was taken during anesthesia. 
Trapping was conducted in two major areas with distinct proximities to farm buildings 
(Figure 3.1A, red and orange circles). Each trapping area had an approximate radius of 500 meters. 
At the location near human settlements (Figure 3.1A, orange circle), trapping was conducted in 
two primary locations- hay bales number #1 and number #2 (Figure 3.1B). At the location away 
from farm buildings (Figure 3.1A, red circle), two brush piles (Figure 3.1C) were places where 
trapping were densely conducted. Additional trapping locations along the Little River and within 
the brush pile zone were delineated in yellow lines in Figure 3.4. Trapping locations were adjusted 
to reach the maximum trapping potential. Both serum and tissues (brain and heart) of trapped 
rodents were collected, whereas only sera were collected from trapped mesopredators. Tissues of 
meso-predators were not collected unless animals were previously tested as seropositive for T. 




trapped animals or heifers were tested via Modified Agglutination Assay (MAT) (Dubey and 
Desmonts, 1987). The cutoff value was set at 1:25 which is the commonly used cutoff value 
(Dubey et al., 1995a and 1995b); however, results using 1:50 as cutoff were also summarized for 
comparison.  
Results 
Soil oocyst detection 
To test the efficacy of the methodology, namely oocyst extraction in conjunction with PCR-RFLP 
detection, we spiked 105 or 106 H. hammondi into 5 or 10 grams of T. gondii-negative soil samples. 
We were able to detect H. hammondi from 5 or 10 grams of soil with 105 or more oocysts, which 
indicated that the methodology was effective (Figure 3.5). To determine where the oocysts 
concentrate in the centrifuged sugar solution, the aqueous layer (denoted with a letter “T”) and the 
interphase (denoted with a letter “I”) were collected separately at the early stage of the study; and 
the combined aqueous layer and the interphase were taken during the later period of this study. H. 
hammondi was detected in solution from the interphase (Figure 3.5, P3I and P4I) or in mixed 
solution combining the interphase and the aqueous layer (Figure 3.5, P2TI), but not in top aqueous 
layer (Figure 3.5, P1T, P3T and P4T), indicating that H. hammondi oocysts concentrate in the 
interphase.  
DNA extracted from the concentrated oocysts from 5 grams of soil were subjected to PCR-
RFLP. On a 96-well plate, 25 percent of negative controls (sample to negative control ratio equals 
to 3:1) were incorporated in the PCR-RFLP, for which DNA was replaced by water in PCR 
reaction mix (Figure 3.5, Table 3.2). Positive controls using DNA from T. gondii (PTG strain), N. 
caninum, and H. hammondi were also included (Figure 3.5, Table 3.2). The same experiment was 
repeated the following day (Figure 3.5B). In the first test, T. gondii appeared in the positive 
controls (PTG strain) and in soil samples number # 2 and number # 11 (Figure 3.5A, Table 3.2). 
In the repeat experiment, number # 21 was positive for T. gondii, and earlier positive samples (# 
2 and # 11) were not consistently positive (Figure 3.5B, Table 3.2). For validation, another 5 grams 
of soil from each of the 22 samples were subjected to the same procedure as mentioned above. No 




double the amount of soil would yield positive results. To that end, 10 grams of soil sample were 
processed and subjected to PCR-RFLP (Table 3.3). No positive samples were detected. The 
inconsistency of positive results across the independent tests suggests that the oocyst concentration 
in the 22 soil samples was low relative to the sensitivity of the detection system.  
Rodent trapping and T. gondii detection 
Total forty rodents, both wild and domestic, were trapped with blood and tissue samples (heart and 
brain) taken (Figure 3.4; Table 3.1). Serum samples were obtained from these 40 rodents, including 
twenty-seven house mice, one brown rat, five white-footed mice, six cotton rats, and one mole 
(Table 3.1). Two major trapping locations (hay bales number #1 and number #2) for domestic 
house mice were indicated in Figure 3.1B and Figure 3.5. House mice were captured close to 
human settlements (Figure 3.1A, yellow cycle), whereas the wild rodents were captured in areas 
away from human settlements (Figure 3.1A, red cycle).  
Serological tests via MAT revealed that with a cutoff at 1: 25, 18.5% (5/27) of the house 
mice, 40% (2/5) of white-footed mice, 0% (0/1) of brown rats, 0% (0/6) of cotton rats and 0% (0/1) 
of moles were positive for T. gondii antibodies. However, the positivity of rodents significantly 
decreased with a cutoff set at 1:50. With a cutoff at 1:50, 3.7% (1/27) of house mice and 0% (0/5) 
of white-footed mice were T. gondii seropositive. Brain and heart tissues from 29 rodents, 
including seventeen house mice, five white-footed mice, five cotton rats, one brown rat, and one 
mole, were subjected to PCR-RFLP. DNA was extracted from combined heart and brain tissues 
and was subjected to PCR-RFLP for T. gondii detection. Four samples were positive for T. gondii 
during the first test. However, these four samples were not consistently positive in the subsequent 
experimental tests. Two samples, however, were consistently positive with one being H. 
hammondi and the other being Sarcocystis spp (Table 3.4). No sample was found consistently 
positive for T. gondii, indicating the absence of T. gondii DNA or the extremely low concentration 
of T. gondii DNA in these tissues (Table 3.4).  
Mesopredator trapping and T. gondii detection 
Eighteen opossums were responsible for the sixty-eight captures (Figure 3.6). Due to the repeated 




number # 81, # 43 and # 47 were caught 15, 13 and 9 times, respectively at various locations, 
among which, number # 47 had the largest home range (Figure 3.6). Seventeen raccoons were 
responsible for the 25 captures (Figure 3.6). One otter was captured, but the attempt for blood 
sampling was futile. Two skunks and two farm cats were responsible for 4 and 3 captures, 
respectively (Figure 3.6). Serum samples were obtained from seventeen raccoons, sixteen 
opossums, two farm cats, and two skunks (Table 3.1). When the cutoff value was set at 1:25, 70.6% 
(12/17) of raccoons and 50% (1/2) of farm cats, 0% (0/16) of opossums and 0% (0/2) of skunks 
were serologically positive for T. gondii (Table 3.1). When cutoff value was set at 1:50, 52.9% 
(9/17) of raccoons and 50% (1/2) of farm cats positive for T. gondii (Table 3.1). All thirty heifer 
serum samples were negative for T. gondii antibodies. Attempts to isolate parasites from animal 
tissues was not conducted due to no recapture of T. gondii seropositive animals. Raccoons number 
# 74 and number # 88 were recaptured and were seropositive at titer 1:100 and 1:25, respectively. 
No parasite isolation was attempted due to their low titer (>=1:50) based on the first serological 
test before the final titration.  
Discussion 
The stability, high infectivity, and abundance of oocysts ensure the perpetuation of the T. gondii 
life cycle, which raises compelling public health concerns. Inadvertently ingesting oocysts 
disseminated in the environmental matrices, such as soil, water, vegetables, and fruits, is an 
important source of human infection of T. gondii. In Brazil, ingesting oocysts in drinking water or 
food was the primary source of infection (Bahia-Oliveira et al., 2003). A myriad of studies have 
substantiated that oocyst-mediated transmission route was more significant than tissue cyst-
mediated transmission. First, oocyst induced infections are more severe than those induced by 
orally ingesting bradyzoites in tissue cysts (Dubey, 1997a; Dubey et al., 1997b). Severe clinical 
toxoplasmosis outbreaks were reported to be linked with ingesting oocysts in water or food (Boyer 
et al., 2011; Bowie et al., 1997; Dubey, 2004; Moura et al., 2006). Second, oocysts are implicated 
in water-related infection, which may lead to the disease of a considerable number of humans and 
aquatic animals (Bowie et al., 1997; Kreuder et al., 2003). Third, oocysts are also associated with 




in North America (Boyer et al., 2011); 43% in Southern Chile (Munoz-Zanzi et al., 2010), and 
80% in swine in Southern Chile (Munoz-Zanzi et al., 2012).  
Among the routes of T. gondii transmission, soil oocyst ingestion is the most implicated in 
animal and human infection. It has been suggested that contacting contaminated soil rather than 
handling pigs is responsible for T. gondii infection in farm workers (Weigel et al., 1999). Children 
are more likely to be infected on account of frequent soil contact (Dattoli et al., 2011; Stagno et 
al., 1980). The soil is the primary environmental matrix harboring oocysts, and through the soil, 
oocysts can be dispersed onto food or into water matrices (Santos et al., 2011; Kreuder et al., 
2003). The presence of oocysts in soil heralds the environmental contamination and poses the risk 
of human and animal infection. However, the environmental contamination by oocyst is largely 
undefined. Published data had suggested that the concentration of oocysts in the environment was 
not evenly distributed and that the detection rate of oocysts in soil was low in random areas. 
However, the soil oocyst contamination rate was shown to be higher in cats’ habitats (Gotteland 
et al., 2014) and their defecation sites (Afonso et al., 2008; Simon et al., 2017). Similarly, a spatial 
distribution of T. gondii oocysts in the soil has been investigated on a farm, in which the soil oocyst 
contamination rate plummets with distance from cat habitats (Gotteland et al., 2014). However, in 
our study, we were unable to consistently detect oocyst in the 22 soil samples collected from two 
cat habitats. The lack of positive sample signifies the absence of oocysts, or the extremely low 
concentration of oocyst in the soil, which falls below the detection limit of our tests. Our results 
coincide with the publication by Davis et al., in which no positive sample was detected from the 
120 soil samples collected from the University of Hawaii at Mãnoa (Davis et al., 2017). However, 
our study contradicts a report of high oocyst contamination rate (30.3%) in soil; nine thousand soil 
samples were collected from Harbin, a northeastern city, in China; random locations to represent 
land use and vegetative cover were chosen for soil collection (Gao et al., 2016). 
Sugar floating technique was widely used to isolate oocysts from soil samples to eliminate 
PCR inhibitors such as humic acid (Lelu et al., 2011). However, the sugar floating process also 
might lose a certain number of oocysts. A recent study had modified the conventional floating 
method by underlying a sugar solution with the soil suspension, generating a 10-fold higher yield 
(Lelu et al., 2011). The detection sensitivity of oocysts in soil depends on oocyst sporulation status, 




reveal higher recovery rates (Lelu et al., 2011). With one-year-old or younger oocysts, a minimum 
detectable concentration of 100-1000 oocysts per gram of soil has been reported (Afonso et al., 
2008).  
Three cycles of free-thaw were shown to be effective to lyse oocyst for subsequent DNA 
extraction (Manore et al., 2019). NucleoSpin soil DNA extraction kit (Macherey-Nagel, Cat. No. 
740780) outcompeted four other DNA extraction kits in the detection of 50 spiked T. gondii 
oocysts per gram of fecal sample (Herrmann et al., 2011). However, the DNA extraction process 
also lost DNA as evidenced by a 100-time detection limit difference with or without DNA 
extraction using lysed oocyst (Gerhold et al., 2015). In our study, attempts were made to detect T. 
gondii directly from lysed oocyst without DNA extraction according to Gerhold et al. However, 
concerns regarding PCR inhibition (inhibitors in the soil) as well as T. gondii contamination 
strangled the continuation of directly using oocyst lysates for PCR; therefore, DNA extraction was 
conducted before PCR detection. In our method of PCR-RFLP following sugar floating and DNA 
extraction , we were able to detect H. hammondi DNA from 5 grams of soil experimentally seeded 
with 105 and 106 H. hammondi oocysts.  
In addition to using soil contamination to evaluate the contamination rate of the farm, 
animal infection was investigated. Animals, either domestic animals or wild animals, contract 
infections via ingesting oocysts disseminated in feeds, water, and soil (Weigel et al., 1995; 
Lehmann et al., 2003). Oocysts have been found in pig feeds, soils, and water (Weigel et al., 1995). 
Therefore, the seroprevalence of farm animals can help to assess T. gondii contamination on the 
farm. It has been shown that the infection of farm-associated animals was closely associated with 
the density of cats and their activities. The infection rate of finishing pigs positively correlates with 
the number of cats on farms (Weigel et al., 1995). There was a positive correlation between the 
seroprevalence of wild animals and the proximities of their habitats to pig stiles where cats 
frequently roamed (Lehmann et al., 2003).  
A partition of animal species was observed as wild and domestic rodents were captured in 
landscapes with distinct proximities to human settlements. Twenty-seven house mice and one 
brown rat were captured in the areas close to farm buildings, that were hay bale #1 and #2 (Figure 
3.1B and 3.4); whereas the wild rodents, including five white-footed mice, seven cotton rats, and 




However, one house mouse was caught in the woods away from human households (Figure 3.1C 
and 3.4). 
Several serological tests for T. gondii antibody examination have been developed in the 
laboratory. Sabin-Feldman dye test (DT) used to be the benchmark of the serological test but was 
replaced due to the safety issues of working with live parasites (Dubey et al., 1988). The indirect 
fluorescent antibody test is highly specific but is complicated due to the involvement of fluorescent 
microscope and fluorescent-labeled antibodies (Dubey et al., 1988). ELISA shows high sensitivity 
and specificity (Gamble et al., 2005) but requires further refinement of procedures (Dubey et al., 
1995a). MAT is less sophisticated and shows high sensitivity and specificity, thus being widely 
used in serological tests (Shaapan et al., 2008; Afonso et al., 2006; Gamble et al., 1999). One 
caveat of the serological test is that seronegative animals (i.e., rodents and avian) can still harbor 
parasites. Another drawback of the serological test (i.e., MAT) is that it is difficult to determine 
the cutoff value for different species without specific testing. The infection rate of T. gondii in 
small rodents has been reported to be low. A large-scale survey revealed that the infection rate in 
house mice was 0.7% (6/884) (Hejlícek and Literák, 1998). Our MAT results (cutoff: 1:25) showed 
that the seropositivity of house mice and white-footed mice are 18.5% (5/27) and 40% (2/5), 
respectively. The results using cutoff at 1:50 were also listed in Table 3.1. With a cutoff at 1:50, 
the seropositivity in house mice was 3.7% (1/27), and no other rodents trapped was found positive 
for T. gondii. Bioassay in mice or cats is the definitive route for T. gondii detection. The bioassay 
was not conducted in our study because serum samples were either positive at low titer or negative. 
Taken together, the serological testing of rodent serum sample is not a good indicator of T. gondii 
infection.  
It has been known that T. gondii infection rate in cattle is low and that cattle are resistant 
to T. gondii infection (Dubey et al., 2005). No positive sample was identified in the thirty heifer 
sera, which coincided with previous studies. Among the trapped mesopredators, the raccoon had 
the highest infection rate (70.6%). In addition, one farm cat (50%) was infected, suggesting the 
previous shedding of oocysts onto the farm. The higher infection rate of T. gondii in raccoons is 
likely because being generalists, they have a broad spectrum of food sources. Further, raccoons 
are susceptible to T. gondii infection. A recent study has shown that 59.2% (32/54) of raccoons 




(Dubey et al., 2007a). Viable T. gondii was isolated from 5 of the 30 seropositive raccoon samples, 
and 1 of the five skunk samples (Dubey et al., 2007a). In Canada, T. gondii was isolated from 
tissues of 2 raccoons, two feral cats, and one skunk (Dubey et al., 2008b). In our study, the two 
skunks were seronegative for T. gondii. It is perplexing that the sixteen opossums in our study 
were all T. gondii negative. The seroprevalence in opossums varies among studies, and very few 
isolates were obtained from opossums (Jiang et al., 2018). Dubey et al. (1995b) have reported a 
22.7% (29/128) seroprevalence (MAT, cutoff at 1:25) in opossums trapped on 47 swine farms in 
Illinois. However, the bioassay was not deployed to isolate the parasite (Dubey et al., 1995b). 
Gerhold et al. had repoted a 50% (6/12) seroprevalence in opossums from southeastern U.S. 
(Gerhold et al., 2017). The possible explanations for the current observation are, 1) opossums are 
resistant to T. gondii infection, and or, 2) they are immunotolerant to T. gondii in addition to having 
short life-spans as is the case in house mice.   
Conclusions 
Further study of T. gondii infection rate in these animals is imperative to understand not only the 
susceptibility of these animals to T. gondii infection but also the contamination rate of the 
environments where these animals inhabit. Taken together, our study showed that mesopredators, 
especially the raccoon and cat, would be a suitable animal model to monitor T. gondii 
environmental infection. Further research should focus on investigating animal infection as a 
critical parameter to assess the environmental contamination especially in areas with low soil 
contamination. 
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Chapter 3 Appendix 
 
Figure 3. 1 Soil sampling and animal trapping locations on the Little River farm. A) Two 
trapping locations, near farm buildings and near the forest, were marked in yellow and red circles 
with different proximities to human settlement. B) Two soil sampling locations were marked in  
red circles; two trapping locations were marked in white circles. C) The two major trapping 









Figure 3. 2 Two locations for soil sample collection. A) location #1 is the calf raising area where 
cats were found feeding, resting and free-roaming. Location #2 is the maintenance shop and silage 
storage area where cats were seen free-roaming. B) A schematic presentation of the sugar floating 















Figure 3. 3 Trapping dates and statistics. (a). The first trapping period (09/2016 – 11/2016). 
Trapping only targeted small rodents. Sherman traps (50-90) were set on the farm property in the 
evening and examined the following morning. Sample from one trapped house mouse was not 
obtained due to handling error (b). The second trapping period (12/2016 – 4/2017). Trapping 
targeted small rodents and mesopredators during this period, although rodent trapping was 
terminated after 3/5/2017. Sherman traps (50-90) and Tomahawk traps (10) were set on the farm 
property in the evening and examined in the following morning. Animals in cages were counted 
regardless of recapture or the success of blood sampling. Trips with no animal captured were 












Figure 3. 4 Locations for animal trapping as well as soil sampling on the farm. House mice 
were trapped in hay bale #1 and #2 (white circles); wild rodents and meso-predators were trapped 
along/across the river, along the woods, and around two brush piles. Soil was collected from two 















Figure 3. 5 Soil oocyst detection via PCR-RFLP. Either the top aqueous layer (T) or the 
interphase(I) or both (TI) were collected. PCR-RFLP was performed after DNA extraction. N 
denotes negative control. M denotes marker. Positive controls are DNA from T. gondii (PTG), N. 
caninum (Nc-1), and H. hammondi (Hh). 105 (in the case of P1T, P3I, P3T) or 106 (in the case 
of P2TI, P4I, P4T) H. hammondi oocysts were spiked in 5 grams of soil samples to test the 











Figure 3. 6 The trapping locations of meso-predators on the farm based on GPS coordinates. 
Each teardrop is one GPS coordinate. At each GPS coordinate, total number of animals captured 
or recaptured were counted; animal species and ID (ear tag No.) were also indicated. Opossum 











Titer % positive sera (cutoff 
at 1:25) 
% positive 
sera (cutoff at 
1:50) 
<25 25 50 100 200 400 800 1600 10,000 ³ 20,000 
House 
mouse 27 22 4 1 0 0 0 0 0 0 0 18.5% (5/27) 3.7% (1/27) 




5 3 2 0 0 0 0 0 0 0 0 40% (2/5) 0 
Cotton rat 6 6 0 0 0 0 0 0 0 0 0 0 0 
Mole 1 1 0 0 0 0 0 0 0 0 0 0 0 
Raccoon 17 5 3 0 2 0 2 1 2 1 1 70.6% (12/17) 52.9% (9/17) 
Opossum 16 16 0 0 0 0 0 0 0 0 0 0 0 
Farm cat 2 1 0 0 0 0 0 0 1 0 0 50% (1/2) 50% (1/2) 











The first 5g of soil with DNA extractiona 
Test #1 (7/11/16) Repeat #1 (7/12/16) 
Top Interphase Top Interphase 
#1c Nb Not done N No done 
#2d T. gondii  N 
#3 N N N N 
#4 N N N N 
#5 N N N N 
#6 N N N N 
#7 N N N N 
#8 N N N N 
#9 N N N N 
#10 N N N N 
#11 N T. gondii  N N 
#12 N Band pattern unknown N N 
#13 N N N N 
#14 N N N N 
#15 Band pattern unknown Band pattern unknown 
Band pattern 
unknown N 
#16 N N N N 
#17 N N N N 
#18 N N N N 
#19 N N N N 
#20 N N N N 
#21 N N T. gondii  N 
#22 N N N N 
T. gondii T. gondii T. gondii 
H. hammondi H. hammondi H. hammondi 
N. caninum N. caninum N. caninum 
Negative 
controls 
Total 18 negative controls were included, 
and all were negative 
Total 18 negative controls were included, and all 
were negative 
Soil sample 
spiked with H. 
hammondi 
P1 N P1 N 
P2 H. hammondi P2 H. hammondi 
P3T N P3T N 
P3I H. hammondi P3I H. hammondi 
P4T N P4T N 
P4I H. hammondi P4I H. hammondi 
 
aDNA was extracted from the soil extracts and then used for PCR-RFLP.  P1 and P3 were positive controls 
in which 105 H. hammondi oocysts were spiked in 5 grams of soil; P2, P4 were positive controls in which 
106 H. hammondi oocysts were spiked in 5 grams of soil. 
bN: negative result. 
cOnly top layer was collected for this sample 




Table 3. 3 PCR-RFLP results of 22 soil samples (another five or ten grams of soil) collected 
from the little river farm.  
Sample ID 
a5g of soil-7/14/2016 b10g of soil-9/10/2016 
Test #1 Repeat #1  Test #1 Repeat #1 
#1 Not done Not done N T. gondii 
#2 Not done Not done N N 
#3 cN N H. hammondi H. hammondi 
#4 Not done Not done N N 
#5 N N N H. hammondi 
#6 Unknown band pattern N H. hammondi N 
#7 N N N N 
#8 N N H. hammondi H. hammondi 
#9 N N N N 
#10 N N N N 
#11 N N N Unknown band pattern 
#12 Unknown band pattern N 
Unknown band 
pattern 
Unknown band pattern 
#13 N N Unknown band pattern 
Unknown band pattern 
 
#14 N N Unknown band pattern 
Unknown band pattern 
 
#15 N N Unknown band pattern 
Unknown band pattern 
 
#16 N N N N 
#17 N Unknown band pattern N T. gondii 
#18 N N Unknown band pattern Unknown band pattern 
#19 N N N N 
#20 N N N N 
#21 N N Unknown band pattern T. gondii 
#22 N N Unknown band pattern T. gondii 
T. gondii T. gondii T. gondii 
H. hammondi H. hammondi H. hammondi 
N. caninum N. caninum N. caninum 
Negative controls Total 15 negative controls were included, and all were negative 
Total 18 negative controls were included; one 
was positive with T. gondii, and one was 
positive with H. hammondi 
dSoil sample spiked 
with H. hammondi 
P16-1 H. hammondi #23-1 N P16-2 H. hammondi 
P19-1 H. hammondi #23-2 N 
P19-2 H. hammondi #24-1  H. hammondi 





a,bDNA was extracted from another 5 grams or 10 grams of soil from each sample.  
bTo test if double the soil quantity would yield better results, ten grams of soil sample was subjected to 
sugar flotation, DNA extraction, and PCR-RFLP.  
cN denotes negative result 




























Table 3. 4 PCR-RFLP results of 29 rodent tissue samples collected from the little river farm.  
 
aSample ID 
cThe first DNA extraction (11/18/2016) 












925HM2 T. gondii Unknown band pattern 
Unknown 
band pattern 
bN T. gondii 
1023HM1 H. hammondi H. hammondi H. hammondi H. hammondi H. hammondi 
1029HM1 T. gondii T. gondii T. gondii N N 
1029CR1 T. gondii N T. gondii N N 
1113HM1 T. gondii N N N N 


















Eight negative controls were included, and one was positive 
for T. gondii  
T. gondii T. gondii T. gondii 
H. 
hammondi H. hammondi H. hammondi 
N. caninum N. caninum N. caninum 
 
a Twenty-nine rodent tissues were included for T. gondii detection using PCR-RFLP. DNA was extracted 
from tissue homogenate. Samples that were initially tested negative were not included in this table; these 
twenty-two samples included 94HM1, 910rat, 925HM3, 925HM4, 917HM1, 924WM1, 917HM2, 
924WM2, 924HM1, 924HM2, 924WM3, 924HM3, 925HM1, 1023HM2, 1023HM3, 925WM1, 1022HM1, 
1022WM1, 1029CR2, 1029mole, 1113CR2, 1114CR1.The seven samples that were tested positive were 
subjected to further testing as listed in this table.  
b N: negative result 
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Abstract   
Toxoplasma gondii is a common cause of mortality in macropods, but there are limited reports of 
the genetic characterization of T. gondii infecting captive macropods in North America. A novel 
genotype, ToxoDB PCR-RFLP genotype #263, was reported from six wallabies at a zoological 
facility in Virginia, USA, prompting an investigation into the genotypes infecting macropods at a 
zoological park in Florida, USA. Cardiac samples from an agile wallaby (n = 1), red kangaroos (n 
= 8), red-necked wallaby (n = 1), and a tammar wallaby (n = 1) that died between 2014 and 2018 
were collected. All 11 cases were confirmed to be infected with T. gondii via serology, 
histopathology, or parasite isolation. A mouse bioassay was used for parasite isolation, and isolated 
parasites were subjected to multilocus PCR-RFLP genotyping of T. gondii. Two cases of 
toxoplasmosis were identified as the reported novel genotype, ToxoDB PCR-RFLP genotype 
#263, but no common source of exposure could be identified between the two zoos. In addition, 
five cases were identified as ToxoDB PCR-RFLP genotype #2 (type III strain), and four cases 
were identified as ToxoDB PCR-RFLP genotype #216, a genotype that has been previously 
reported in wildlife in North America. In addition, a freckled duck that died of toxoplasmosis at 
the same park was genotyped as genotype #2. These results suggest that at least three distinct 
sources and transmission events occurred at this park between 2014 and 2018. Genotype 
identification can aid in understanding the sources of infective oocysts in a geographic area and 
determining whether multiple mortalities are due to single or multiple exposure events. Further 
research is needed to determine whether different genotypes vary in pathogenicity in macropods 
and to identify effective preventive measures for captive macropods 
 








Toxoplasma gondii is a zoonotic intracellular parasite with a worldwide distribution and broad 
host spectrum, including mammals and birds (Dubey, 2010). Felidae are the sole definitive host, 
with the ability to discharge millions of oocysts into the environment (Dubey et al., 2011). Host 
infection occurs through ingestion of oocysts dispersed in the environment, consumption of meat 
containing parasite tissue cysts, or vertical transmission during pregnancy (Dubey et al., 2011). 
Infection in immunocompetent animals is generally asymptomatic but can cause illness, including 
respiratory or neurologic clinical signs, decreased reproductive success, and/or mortality (Dubey, 
2010). Latent asymptomatic infection with subsequent recrudescence can occur as well (Dubey, 
2010; Portas, 2010). Macropods, including kangaroos and wallabies, are particularly susceptible 
to infection and death in North American zoos due to toxoplasmosis (Guthrie et al., 2017; Portas, 
2010).  
There are over 180 reported genotypes of T. gondii, and different genetic lineages exhibit 
distinct geographic distribution (Shwab et al., 2014). In North America, the most commonly 
reported lineages include ToxoDB PCR-RFLP genotypes #1 and #3 (collectively known as type 
II), genotype #2 (known as type III) in domestic animals, and genotypes #4 and #5 (collectively 
known as type 12) in wildlife (Dubey et al., 2011; Shwab et al., 2014). Certain genotypes are 
associated with more severe clinical disease in humans, but the relationship between T. gondii 
genotype and clinical disease in animals, including macropods, is unknown (Calero-Bernal et al., 
2015; Dubey et al., 2013; Su et al., 2012). A novel genotype, ToxoDB genotype #263, was reported 
in six wallabies that died at the Virginia Zoo (Norfolk, Virginia, USA) in 2014 (Guthrie et al., 
2017). Three other wallabies from this zoo were infected with the genotype #4 strain, which was 
previously reported in North American wildlife (Guthrie et al., 2017). By identifying the T. gondii 
genotypes infecting captive macropods at a particular facility, one may better infer the number of 
sources of infective oocysts during toxoplasmosis outbreaks and the pathogenicity of different 
strains. Here, we attempted to isolate and/or genotype T. gondii from eleven fatal toxoplasmosis 




Materials and Methods  
Animals, collection of samples, histopathology, and medical record review   
Between 2014 and 2018, serum and fresh cardiac muscles were collected from a subset of 
macropods that died due to suspected or known toxoplasmosis at a single zoological facility in 
Florida, USA for T. gondii isolation and characterization. Species from which parasites were 
isolation included red kangaroo (Macropus rufus, n = 4), agile wallaby (Macropus agilis, n = 1), 
and tammar wallaby (Macropus eugenii, n = 1). Cases were selected for parasite isolation 
opportunistically based upon the availability of personnel to complete the sampling and laboratory 
mice for the bioassay isolation. The combined frozen heart and lung were used from five additional 
cases for PCR-RFLP genotyping, including red kangaroo (n = 4) and red-necked wallaby 
(Macropus rufogriseus, n = 1). Additionally, cardiac muscles from a freckled duck (Stictonetta 
naevosa, n = 1) that died of toxoplasmosis at the same park was genotyped following the same 
methods. The same veterinary pathologist performed a gross necropsy for each case. Tissues were 
preserved in 10% neutral buffered formalin and stained with hematoxylin and eosin (H & E) for 
histopathologic examination. Fresh cardiac and serum samples were refrigerated at 1.7-3.3°C, and 
frozen samples were stored at -20 °C. Samples were shipped overnight to the Department of 
Microbiology at the University of Tennessee (Knoxville, Tennessee, USA) for T. gondii detection, 
isolation, and genetic characterization.  
Medical and necropsy records of macropods that died between 2014 and 2018 at a 
zoological facility in Florida, USA were retrospectively reviewed for cases of toxoplasmosis, and 
information was collected regarding the clinical signs and treatment of the 11 cases reported herein 
(Table 1).  
Serologic testing 
Serum was collected ante- or postmortem from 7 of the 11 cases. Competitive enzyme-linked 
fluorescence assay (ELFA, n = 3) or modified agglutination test (MAT, n = 4) was used to detect 
T. gondii antibodies using previously described methods. For ELFA, a positive test value threshold 




MAT, a positive dilution cutoff value of 1:25 was used by the method described previously (Dubey 
and Desmonts, 1987). 
Ethical statement 
All procedures of mouse experiment were approved by the Institutional Animal Care and Use 
Committee (University of Tennessee, IACUC protocol number 1419). 
Bioassay to isolate T. gondii in mice  
Bioassays were conducted in accordance with a previously described method (Dubey, 2010). 
Briefly, five grams of heart tissues or heart and lung combined were cut into small pieces and 
transferred into a 20 ml DT-20 dispenser tube (IKA ULTRA-TURRAX, Sigma-Aldrich, USA). 
Fifteen milliliters of saline (0.85% NaCl) were added to the tube. The tissues were homogenized 
using the IKA ULTRA TURRAX Tube Drive homogenizer (IKA ULTRA-TURRAX, Sigma-
Aldrich, USA). One hundred microliters of homogenized tissue (approximately 100 mg) were 
taken for DNA extraction using DNeasy Blood and Tissue kit (Qiagen; Cat No. 69504). The 
homogenized tissues were digested with acid pepsin (Sigma, # P7000-25G) at 37°C for 40-60 min. 
The digested tissues were gauze-filtered and washed by PBS and resuspended in PBS containing 
10mg/ml gentamicin. One milliliter of prepared tissue in PBS, containing10 µg of gentamicin, was 
injected intraperitoneal to each of three outbred CD-1 mice to isolate the parasites. Dexamethasone 
phosphate (15 µg/ml) was added in the drinking water to suppress mouse immune response for 
better parasite isolation. Mice showing symptoms of T. gondii infection (rough fur, lethargy) 
between day 6 and day 12 were euthanized. Five milliliters of PBS with gentamicin were injected 
into the peritoneal cavity, and the exudates were collected. One milliliter of peritoneal lavage was 
spun down and resuspended in 100 µl PBS and subjected to DNA extraction using the Qiagen kit 
above. DNA was eluted in 100 µl of buffer AE. 
Genotyping of T. gondii samples 
DNA samples directly extracted from heart tissue or combined heart and lung tissues or from 
peritoneal lavage of infected mice were subjected to PCR-RFLP typing using 10 genetic markers 





Between 2014 and 2018, there were 27 macropod mortalities identified in which toxoplasmosis 
was suspected based on histopathology (Fig. 4.1). Species affected included agile wallaby (n = 7), 
red kangaroo (n = 15), red-necked wallaby (n = 3), tammar wallaby (n = 1), and western gray 
kangaroo (Macropus fuliginosus, n = 1). Of these, 15 were acute or peracute cases of 
toxoplasmosis, and 12 had another type of concurrent disease or chronic visual impairment 
possibly due to ocular toxoplasmosis and were euthanized. Mortality dates for the animals 
described in this reported are as follows: May 2014 (red kangaroo, n = 1; agile wallaby, n = 1), 
July 2015 (red-necked wallaby, n = 1), September 2015 (red kangaroo, n = 1), April 2017 (red 
kangaroo, n = 1), September 2017 (red kangaroo, n = 1), October 2017 (tammar wallaby, n = 1; 
red kangaroo, n = 1), December 2017 (red kangaroo, n = 1), February 2018 (red kangaroo, n = 1) 
and May 2018 (red kangaroo, n = 1) (Fig. 4.1). Clinical signs, treatment, serology results, and 
necropsy findings from these 11 cases are summarized in Table 1. Peracute or acute death occurred 
in 9 of the cases, while two of the cases had clinical signs for 3-4 days in duration. Case #6 was 
euthanized due to a deteriorating clinical condition. Clinical signs varied in each case but included 
lethargy, inappetence, tachypnea, recumbency, and seizures. Various treatments were attempted 
in five cases, including subcutaneous fluid therapy, antibiotics, antiprotozoals, and a diuretic. Six 
of the seven cases tested were seropositive at the time of death. MAT titers ranged from 1:50 to ³ 
8192. The agile wallaby in case 2 had a peracute mortality and was seronegative at the time of 
death.  
Toxoplasmosis was determined to be the cause of death in 10 of the cases. Concurrent 
conditions were identified in some cases, including gastrointestinal ulceration with intralesional T. 
gondii and Entamoeba (case 1), chronic ascending cholecystitis (case 2), gastric nematodiasis 
(cases 3, 4, 10), gastric foreign material (case 4), minimal otitis externa (cases 7 and 10), jugular 
hematoma (case 8), entamoebiasis of proximal saccular stomach (case 10), and bacterial dermatitis 
of the pouch (case 10). In case 6, methemoglobinemia was determined to be the cause of death, as 
it was severe enough to account for the clinical deterioration necessitating euthanasia. Although 




Heart tissues from cases 1, 2, 6, 8, and 9 were used for bioassay to isolate T. gondii. Three 
isolates were obtained from three red kangaroos (cases, 1, 6, 8) and designated as TgKgrFL1, 
TgKgrFL2, and TgKgrFL3 (Table 2). Mice inoculated with heart tissue of case 2 (agile wallaby) 
did not show obvious symptoms by day 14 post-infection. In this case, T. gondii was not isolated, 
and genotyping was performed using heart tissue DNA. Mice inoculated with tissue of case 9 (red 
kangaroo) were severely sick on day 2 post-infection, possibly due to toxic products from 
degradation of the tissue (20 days post collection) and were euthanized. Heart tissue DNA was 
subsequently used for genotyping of case 9. Case 8 was genotyped using both parasite isolate and 
heart tissue DNA. The remaining cases were not bioassayed at the time of death, and genotyping 
was performed using either fresh or frozen heart tissue DNA (Table 2). 
Genotyping results revealed ToxoDB genotype #263 (cases 1 and 2), genotype #2 (cases 
3, 4, 5, 6, 11), and genotype #216 (cases 7, 8, 9, 10) (Table 2). Additionally, a freckled duck from 
an aviary adjacent to the macropod exhibit died of toxoplasmosis in July 2017 and was confirmed 
to be genotype #2 using tissue DNA from combined heart and lung.  
Discussion 
Toxoplasmosis is commonly reported in captive macropods (Basso et al., 2007; Dubey and 
Crutchley, 2008; Guthrie et al., 2017), and the outbreak occurred from May-June 2014 in this 
report is unremarkable. Acute toxoplasmosis progresses rapidly, and sudden death can occur 
(Miller et al., 1992, Patton et al., 1986). Treatment was initiated for toxoplasmosis when possible 
based on clinical signs and included antiprotozoals, antibiotics, subcutaneous fluids, and diuretic 
for treatment of pulmonary edema. Treatment varied depending on the presentation of the animal 
and preference of the attending veterinarian. In one report, a trimethoprim and sulfadiazine 
combination was used to treat acute toxoplasmosis in wallabies with marginal or no effect (Miller 
et al., 1992). Dubey and Crutchley (2008) have reported successful treatment of toxoplasmosis in 
four Bennett’s wallabies using atovaquone. Atovaquone has been shown to have a synergistic 
effect when administered together with pyrimethamine, clindamycin, or sulfadiazine (Dubey and 




despite treatment with atovaquone. The effect of treatment varies from case to case (Jensen et al., 
1985; Guthrie et al., 2017) but is generally deemed unrewarding (Portas, 2010).  
Serologic testing was not clinically useful for antemortem diagnosis in most cases at this 
facility due to the rapid progression of clinical signs and death and possibility for a negative result 
as seen in case 2 likely due to insufficient time for antibody production or a positive titer due to 
chronic or latent infection (Basso et al., 2007; Mayberry et al., 2014). If the clinical course were 
long enough to allow repeated testing, the demonstration of a rising titer would support the 
diagnosis of toxoplasmosis (Miller et al., 2003).  
We confirm the T. gondii genotypes #263, #2, and #216 from the 11 cases of toxoplasmosis 
from a zoological park in Florida. This is the first report of genotype #216 in captive macropods. 
Although little is known about the genetic characterization of T. gondii infection of wild 
macropods, there have been several reports of the parasite’s genotyping from captive macropods. 
Genotype #263 (which does not belong to any clonal type) and #4 (clonal type 12) were responsible 
for the death of six and three red-necked wallabies in Virginia Zoo, respectively (Guthrie et al., 
2017). Genotype #263 has only been found in the Virginia wallabies and in cases 1 and 2 reported 
here to date. It is possible that some or all of the other mortalities that occurred during the May-
June 2014 outbreak, along with cases 1 and 2, were due to this same genotype. It is interesting to 
note that this strain was associated with a larger number of mortalities than typical at this zoo in 
Florida as well as at the Virginia Zoo as reported by Guthrie et al. (2017). It is unknown if this is 
coincidental or due to increased pathogenicity of genotype #263 in macropods. In humans, atypical 
genotypes have been reported to cause severe toxoplasmosis in patients without immune 
compromise (Dubey et al., 2011). Because genotype #263 is only reported from macropods from 
these two facilities, the potential for a common source exposure was investigated. None of the 
affected animals were ever housed at the same facility, and the food sources (both concentrate 
ration and hay) were confirmed to be different at each facility (M. Spriggs, pers. comm.). Clonal 
type III (ToxoDB PCR-RFLP genotype #2) was the one of the four clonal genotypes highly 
prevalent in animals in North America and was isolated from one tammar wallaby and two 
Bennett’s wallabies (Macropus rufogriseus) in Pennsylvania (Dubey and Crutchley, 2008; Dubey 
et al., 2011; Jiang et al., 2018). Two T. gondii strains were isolated from one eastern grey kangaroo 




III, respectively (Moré, et al., 2010). Genotype #6 was isolated from a captive Tammar wallaby 
from National Zoo (District of Columbia, USA) and is also found in Africa and Brazil, while an 
atypical strain with an undetermined genotype caused the death of a Bennett’s wallaby in Spain 
(Dubey et al., 2011; Fernández-Aguilar et al., 2013). In North America, genotype #216 has been 
identified in white-tailed deer (Odocoileus virginianus, n = 4), red fox (Vulpes vulpes, n = 4), black 
bear (Ursus americanus, n = 2), and feral cats (Felis catus, n = 2) (Jiang et al., 2018).  
From May-June 2014 outbreak of 11 mortalities, two cases were genotype #263, while two 
cases between July and September 2017 were genotype #2, and three cases between October 2017 
and February 2018 were genotype #216, suggesting that at least three different sources of 
infections or three transmission events occurred. Precipitation was higher than average in May 
2014 at this facility. It has been suggested that heavy rains may periodically wash infective oocysts 
into the macropod and adjacent exhibits, but other sources have not been ruled out. Prevention of 
toxoplasmosis in captive macropods is challenging given that there is no vaccine, prophylactic 
therapy, or practical and effective means of environmental decontamination. Prevention of 
exposure to infective oocysts remains key and includes eliminating feral or wild felids from zoo 
grounds as well as any place where they have the potential to contaminate food or water sources. 
It may also be prudent to design macropod exhibits in a way that prevents storm water, a potential 
source of infective oocysts, from running into the exhibit.  
Toxoplasma genotyping in captive macropods can provide insights into exposure and 
transmission of the parasite within a group and over various timelines. It remains to be determined 
whether certain strains are more pathogenic than others, and the prevalence of genotype #263 in 
felids or other wildlife species is unknown. Ongoing research into the prevalence, pathogenicity, 
and transmission of various genotypes within a geographic area is needed. This information can 
help inform prevention strategies to reduce the effects of this important disease in captive 
macropods.  
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Figure 4. 1 The 20 mortalities of macropods between 2014 and 2018 in Busch Gardens, 
Florida. The genotypes of the 11 cases reported in this study were indicated in the figure. The 
mortality dates for the animals described in this reported are as follows: May 2014 (red kangaroo, 
n = 1; agile wallaby, n = 1), July 2015 (red-necked wallaby, n = 1), September 2015 (red kangaroo, 
n = 1), April 2017 (red kangaroo, n = 1), September 2017 (red kangaroo, n = 1), October 2017 
(tammar wallaby, n = 1; red kangaroo, n = 1), December 2017 (red kangaroo, n = 1), February 




          Table 4. 1 Toxoplasma gondii genotype, signalment, clinical signs, serology results, treatment, and necropsy findings from 11 macropod      








Species Sex Location 







































Fluid therapy2 None 



































7/24/2015 1.6 Found dead Peracute 
death 
Not done  None None 




9/11/2015 6.0 Diarrhea 1 Positive 












4/6/2017 0.5 Found dead  Peracute 
death 














Species Sex Location 
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<1 day Positive 






















Not done None None 







2/18/2018 1.3 Lethargy, 
shaking, 
tachypnea 




















2Lactated Ringer’s Injection USP (Hospira, Lake Forest, Illinois, USA), 40 ml/kg, SQ (case 1); 32 ml/kg, SQ (case 4); 27 ml/kg, SQ (case 6); 22 ml/kg, SQ (case 
8) 
3Sulfadimethoxine/pyrimethamine suspension (250 mg/ml and 12.5 mg/ml), 32 mg/kg, PO 
4ExcedeÒ ceftiofur crystalline free acid (200 mg/mL, Zoetis, Parsippany, New Jersey, USA), 5.4 mg/kg, SQ (case 8); 6.5 mg/kg, SQ (case 10) 
5MarquisÒ (15% w/w ponazuril, Merial, Duluth, Georgia, USA), 1.6 mg/kg, PO (case 3); 21.4 mg/kg, PO (case 10) 
6Mepron® Atovaquone suspension (750 mg/5 ml, GlaxoSmithKline, Philadelphia, Pennsylvania, USA), 21.9 mg/kg, PO (case 8); 97.4 mg/kg, PO (case 10) 





Table 4. 2 Results of PCR-RFLP typing of Toxoplasma gondii from cases of toxoplasmosis in macropods and a freckled duck at a 






























1  Isolate1 and 
tissue2 
I I I I I I III I III I III TgKgrFL
1 
#263 
2  Tissue2 I I I I I I III I III I III  #263 
3  Tissue2 II/III III III III III nd4 III III III III III  #2 
4  Tissue2 II/III III III III III III III III III III III  #2 
5  Tissue2 II/III III III nd III III III nd III III III  #2 
6  Isolate1 II/ III III III III III III III III III III III TgKgrFL
2 
#2 
7  Tissue3 I I I III III I III III III I III  #216 
8  Isolate1 and 
tissue3 
I I I III III I III III III I III TgKgrFL
3 
#216 
9  Tissue3 I I I III III I III nd III I III  #216 
10  Tissue3 I I I III III I III nd III I III  #216 
11  Tissue3 II/III III III III III III III III III III III  #2 
 
1T. gondii parasite isolate from a mouse bioassay was used for genotyping.  
2DNA extracted from heart tissue was used for genotyping.  
3DNA extracted from heart and lung tissues was used for genotyping.  
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Felids are the only hosts that can excrete Toxoplasma gondii oocysts into the environment. Oocysts 
are environmentally resistant and highly infectious. Inadvertent ingestion of oocysts disseminated 
in soil, water, and food accounts for an important route of animal and human infection. Thus far, 
the most effective way to reduce human and animal infection is to reduce the environmental 
contamination by oocyst. Controlling oocyst shedding by cats through the development of a 
vaccine becomes the goal of this study. One dose of an oral live bradyzoite vaccine T263 can 
prevent oocyst shedding in 84% (Frenkel et al., 1991) and 45% (Mateus-Pinilla et al., 1999) of 
cats in laboratory and in field, respectively. Due to its high cost resulting from its cumbersome 
preparation, the vaccine has not been commercialized. To produce the vaccine, T263 is injected 
into mice; a month later, mice brain and heart tissues are harvested, homogenized, and digested 
with pepsin. The vaccine was then fed to cats for immunization. To simplify the vaccine 
production, we investigated two strategies to convert T263 from tachyzoites to bradyzoites in vitro 
to bypass the heretofore required mouse bioassay. We tried vacuum conditions and low 
temperature at 31℃ to switch tachyzoites to bradyzoites in cell culture. Conversion efficacy was 
tested via acid-pepsin digestion, indirect fluorescent assay (IFA), and mouse bioassay. Vacuum 
conditions were able to convert TgCkVe6 strain from tachyzoites to bradyzoites as evidenced by 
the expression of bradyzoite antigen 1 (BAG1) and cyst wall protein (CST1) but was unable to 
convert T263. However, low temperature at 31℃ was able to convert T263 as evidenced by the 
expression of BAG1 and CST1. Low temperature treated T263 were infectious to mice via oral 
route and was more prone to produce brain tissue cysts as compared to untreated T263. To 
conclude, in preliminary experiments, we showed that low temperature (31℃) treatment can 
produce T263 bradyzoites in vitro. Further study should test the whether the in vitro produced 
T263 brayzoites can induce immunity to oocyst shedding in cats.   
 





Toxoplasma gondii is a coccidian parasite that infects a broad spectrum of hosts, including humans, 
animals, and birds (Dubey, 2010).  Infection is ubiquitous as one-third of the global human 
population has been exposed to T. gondii. Toxoplasmosis, the disease caused by T. gondii, has 
been shown to cause social and economic loss (Scharff, 2012; Hoffmann et al., 2012). Notably, 
infection can cause spontaneous abortion, stillbirth or severe congenital disabilities in newborns 
(Dubey, 2010). Infection can cause fatal outcomes in immunocompromised individuals, such as 
AIDS patients and those who undergo radiation therapy for cancer treatment. Immunocompetent 
individuals experience a short period of flu-like symptoms after the initial infection, which is 
followed by an asymptomatic chronic infection. Severe consequences in immunocompetent 
patients manifested as ocular toxoplasmosis, systematic toxoplasmosis, or death, have been 
reported especially in the recent few decades (Holland, 2003; Carme et al., 2009; Demar et al., 
2007).  
Three parasitical stages exist in the life cycle of T. gondii: tachyzoite, bradyzoite, and 
sporozoite (Dubey, 2010; Weiss et al., 2013). Tachyzoites are the fast-replicating form that can 
induce an IFN-γ-dependent host immune response. Bradyzoites are the slow-growing, semi-
dormant stage and are enclosed by cyst walls which sequester parasites to evade host immune 
attack. Sporozoites, the environmental form of the parasite, reside in sporulated ooysts. Upon 
infection, in the pressure of host immune response, tachyzoites are converted to bradyzoites; the 
latter form cysts that reside in host tissues (Skariah et al., 2010). Reactivation of bradyzoites takes 
place in immune-compromised people such as T. gondii-infected AIDS patients (Grant et al., 
1990). During the conversion from tachyzoites to bradyzoites, the gene expression profile altered, 
resulting in a decrease in immunogenic surface proteins, metabolic enzymes, and an increase in 
proteins necessary for the entry into G0 (Blader and Saeij, 2009).  
Concerning surface protein expression, bradyzoite expresses bradyzoite antigen 1 (BAG1). 
BAG1 protein is a characteristic protein solely expressed on the bradyzoite surface and is therefore 
often used as a marker for bradyzoite identification (Blader and Saeij, 2009). Cells expressing 
BAG1 were seen after 24 hours of exposure to stress such as pH 8.1 (Weiss and Kim, 2011). 




(Bohne et al., 1998). In addition, the formation of cyst wall, often recognized by detecting cyst 
wall protein (CST1), is another hallmark of bradyzoite formation (Blader and Saeij, 2009). The 
exact structure and composition of the cyst wall is not clear but was proved to contain 
polysaccharides and chitin (Boothroyd et al., 1997). The N-acetylgalactosamine contained in a 116 
kDa glycoprotein CST1 accounts for the binding of DBL (Dolichos biflorus lectin) to cyst wall 
(Skariah et al., 2010; Lyons et al., 2002; Fux et al., 2007).  
T. gondii infection is prevalent in humans and animals. The high infection rate in domestic 
animals raised for human consumption poses serious public health concerns. The seroprevalence 
of pigs raised in poorly managed or non-confined facilities is as high as 68% (Dubey et al., 2008). 
Viable T. gondii has been frequently isolated from pork destined for human consumption; isolation 
rates range from 0.3% to 92.7%, depending on the age of pigs and pig farming conditions (Dubey 
and Jones, 2008). Worldwide, chickens raised in the backyard are steadily infected with T. gondii 
with infection rate ranging from 27%- 100% (Dubey and Jones, 2008; Dubey et al., 2005b; Dubey 
et al., 2006). A study conducted in Paraná, Brazil revealed that 12.2% (47/386) of serum samples 
from free-range chickens were T. gondii positive (Vieira et al., 2018). Sheep and goats are 
susceptible to T. gondii infection evidenced by frequent reports of abortion and neonatal mortality. 
Congenitally infected lambs that survived can remain asymptomatic, which could be a source of 
human infection (Dubey and Kirkbride, 1989). Clearly, the high prevalence of T. gondii and its 
concomitant health risk call for methods to intervene its transmission.  
T. gondii is transmitted through three major routes, including ingesting oocysts 
disseminated in the environment, eating undercooked meat that contains tissue cysts, and 
congenital transmission. As the sole definitive hosts able to shed oocysts into the environment, 
cats play a central role in the epidemiology and transmission of T. gondii. Studies have shown that 
T. gondii infection is scarce or absent in areas without cats (Dubey, 1997; Munday et al., 1972; 
Wallace et al., 1969). The facts that cats are widespread and that they are predisposed to T. gondii 
infectioin pose a risk to human health. Approxmiately, one-third of households in the United States 
own cats. There are an estimated 78 million domestic cats and 73 million feral cats in the U.S. 
(Dubey, 2010). An average of 30% of cats worldwide have been infected with T. gondii (Dubey, 




cats was present on each pig farm in Illinois, of which six were seropositive for T. gondii (Weigel 
et al., 1999).  
Thus far, using vaccines to prevent infection has been mostly ineffective. The only 
commercialized vaccine is for sheep, which is a strain (S48) that does not form tissue cysts in 
sheep, used during lambing season to prevent abortion in Europe and New Zealand (Buxton et al., 
1993). A vaccine to directly immunize humans has not yet been available. Many obstacles posed 
in human vaccine production as killed strain provides at best marginal protection and attenuated 
or mutant strains pose the risk of infection especially to fetuses (Dubey, 2010).  
The most effective and rewarding vaccination strategy leans toward the immunization of 
definitive hosts. A 3-year field trial revealed that vaccination of cats on eight commercial farms 
using T263 showed promise to reduce the infection in farm animals (finishing pigs and mice) 
(Mateus-Pinilla et al., 1999). T263 was a mutant produced by exposing tachyzoite to the alkylating 
agent, N-methyl-N’-nitro-N-nitroso guanidine (Frenkel et al., 1991; Popie et al., 1994) and was 
selected for its resistance to adenine arabinoside. T263 is genetically mutated and could not form 
oocyst in the intestinal epithelial cells of the cat (Dubey, 2010). Therefore, oral administration of 
T263 cannot induce oocyst shedding in cats but can induce immunity to oocyst shedding upon 
challenge with a wild strain. The oral administration to cats of the bradyzoite/tissue cyst form of 
T263, not the tachyzoite form, is required to produce immunity to oocyst shedding (Freyre et al., 
1993; Freyre et al., 1993).  
The application of this cat vaccine had been unsuccessful due to several factors, principally 
the cumbersome procedure for preparation and the resulting high cost per dose (Frenkel et al., 
1991; Freyre et al., 1993; Mateus-Pinilla et al., 1999). Mice are required for vaccine production, 
whereby brain tissue cysts are allowed to develop for a month. A month later, mice are euthanized, 
and the brain tissues are harvested and homogenized, digested with pepsin, and preserved in liquid 
nitrogen (Choromanski et al., 1995). At the time of immunization, vaccine is thawed and orally 
admistered to cats.  
To simplify vaccine production and to reduce its price, we sought to develop a 
methodology to produce live bradyzoites in vitro. To achieve that, we aimed to develop a technique 
to convert T263 tachyzoites to bradyzoites in vitro. Previously, low or high pH and heat shock 




attempts, these methods produced significant damage to host cells, which rendered the production 
of bradyzoites inadequate. In this study, we investigated two conversion strategies, namely, 
applying vacuum conditions and low temperate at 31℃. We first tested the effect of vacuum 
conditions on a T. gondii strain isolated from a chicken in Venezuela (Rajendrana et al., 2012). 
The conversion potential of vacuum conditions was inadvertently discovered in TgCKVe6 in an 
event of developing a method to ship cell culture between labs. We were able to slow down the 
growth of T. gondii strains TgCkVe6 and T263 using vacuum conditions and low temperate at 
31℃, respectively. Three approaches were used to evaluate the in vitro produced bradyzoites: 
Indirect fluorescent assay (IFA), pepsin digestion assay, and mouse oral infectivity assay.  
Materials and Methods 
Cell culturing and treatment conditions 
Toxoplasma gondii was routinely cultured in Human Foreskin Fibroblasts (HFFs) in Dulbecco's 
Modified Eagle Medium (DMEM) containing 10% Fetal Bovine Serum (FBS). HFFs were grown 
in either T25 flasks for pepsin digestion assay and mouse bioassay or on glass coverslips inserted 
into 6-well plates for IFA. 
For vacuum conversion treatments, HFFs were infected with TgCkVe6 or T263 in either 
T25 flasks or 6-well plates at 37°C, 5% CO2 overnight for 12h. The next day, media was changed 
to remove cell debris; the T25 flask or 6-well plate with infected HFFs was transferred into a 
vacuum bag. Air in the bag was depleted using handheld rechargeable vacuum sealing system 
(FoodSaver FreshSaver, Walmart # 007428735). The cell culture in flask or plate in a vacuumed 
bag was then incubated at room temperature (20-25°C) for three or four days. Afterward, cell 
culture was transferred back to 37°C, 5% CO2 incubator and kept for another seven to ten days. 
 For low temperate conversion treatment, HFFs were infected with T263 at 31℃ in a T25 
flask or a 6-well plate. Cell culture was then kept at 31℃ for seven to eight days. 
For IFA, 10 to 15 drops of media containing parasites (3–5× 105 parasites) were inoculated 
into each well of a 6-well plate with confluent HFFs on coverslips. For pepsin digestion assay and 





Detection of protein expression via IFA 
The presence of BAG1 and CST1 in in vitro produced bradyzoites were detected using IFA. After 
the conversion treatment, cell culture infected with TgCkVe6 or T263 in a 6-well plate was fixed 
in 4% formaldehyde at RT (room temperature) for 30 mins, permeated with 0.5% Triton at RT for 
20 mins, and blocked with blocking buffer (PBS with 0.1% Triton and 10% BSA) at RT for 1 h. 
Each step was followed by three times of washing with ice-cold PBS. For primary antibody 
staining, monoclonal rabbit anti-BAG1 antibodies (1:100) (Weiss et al., 1992) was added and 
incubated at 4℃ overnight. The next day, upon washing, secondary antibodies Alexa Fluor 594 
goat anti-rabbit IgG (Invitrogen, A11012) at 1:100 were added and incubated at RT for 1 hour. 
Finally, after washing, FITC-conjugated Dolichos biflorus agglutinin (Fisherbrand, FL-1031) at 
1:300 was added for CST1 staining at RT for 1 hour. After incubation, cells on coverslips were 
washed with PBS; coverslips were taken out, air dried, and mounted onto glass slides. Fluorescent 
microscopy (Leica DMRX, Leica Microsystems) was used to detect protein expression. As 
controls, the non-treated parasites (presumably tachyzoites) were subjected to the same IFA 
procedure. 
Pepsin digestion assay 
We utilized an acid-pepsin digestion assay to evaluate the treated parasites by comparing the 
survival rates of treated and non-treated parasites upon pepsin digestion. This method replies on 
the fact that bradyzoites, cell culture-derived or animal tissue-derived, are more resistant to acid-
pepsin (Lyons et al., 2002; Weiss et al., 2011; Popie et al., 1994).  Viable parasites of treated and 
non-treated TgCkVe6 or T263 in a T25 flask were enumerated via plaque assay before pepsin 
digestion. To release parasites from host cells and parasitophorous vacuoles (PVs), we scraped 
host cells from the bottom of the flask and pressed them through a 22-gauge needle in a 10 ml 
syringe four times. Upon washing, parasites from one T25 flask (either treated or non-treated) were 
equally split into two portions: one was subjected to pepsin digestion (0.26 mg/ml pepsin in 
0.170M NaCl, pH1.4), and the other served as negative control in which the base solution (0.170M 
NaCl) was added. Digestion was conducted for 15 or 30 mins at 37℃. The pepsin digestion was 
followed by addition of 1.2% sodium bicarbonate (pH 8.3) to bring the solution to neutral pH. The 




in each of the four groups (treated parasites with pepsin solution, treated parasites with base 
solution, non-treated parasites with pepsin solution, non-treated parasites with base solution) were 
enumerated again via plaque assay. The survival rates of treated and non-treated parasites with or 
without pepsin digestion were compared. 
For plaque assay, cell suspension was serially diluted across a range of 10-1 to 10-4; 
inoculum of 100 µl at each concentration (10-1 to 10-4) was transferred into each well of a 6-well 
plate; plate was incubated at 37 ℃ for seven days. After incubation, cell medium was removed, 
and cells were fixed in 70% ethanol. The plaque number was enumerated under bring light 
microscope. 
Mouse bioassay 
We intended to test whether the in vitro produced T263 bradyzoites can be liquid nitrogen (LN) 
preserved. The 31℃ treated T263 were preserved at seven days post-infection to simulate the 
vaccine preservation. After seven days at 31℃, cell culture was scratched from the flask and mixed 
with 50% FBS in DMEM and was subsequently mixed with 20% dimethyl sulfoxide (DMSO) in 
DMEM. The mixture was then transferred to LN upon overnight on dry ice. After four months, on 
the day of mice infection, in vitro produced bradyzoites were thawed, washed, and resuspended in 
PBS. The number of cysts was enumerated using hemocytometer to prepare 2.5 ×104 cysts/ml in 
5ml PBS. 
We also tested the infectivity of freshly prepared T263 bradyzoites. Seven days post 
infection at 31°C, cells were scraped off from three T25 flasks, washed and resuspended in PBS. 
The number of cysts was counted using hemocytometer to prepare 2.5 ×104 cysts/ml in 5ml PBS. 
Tachyzoites of T263 were included as control. The fast-growing T263 was cultured at 
37 °C and reached a growth speed of 2-day passage. Two days after infection, parasites were 
bursting from host cells. Cell culture was pressed through a 22-guage needle to further separate 
tachyzoites from host cells. The number of tachyzoites was enumerated using hemocytometer to 
prepare 2.5 ×104 tachys/ml in 5 ml PBS.  
Fifteen mice were evenly divided into three groups of five. Each group of mice were 
infected with parasites of a different preparation, namely, LN preserved bradyzoites, freshly 




parasites which contained 2.5 ×104 LN preserved cysts, 2.5 ×104 fresh cysts, and 2.5 ×104 fresh 
tachyzoites. Mice were monitored for three weeks. After three weeks, mice were euthanized; brain, 
heart, and lung tissues were taken for PCR detection of T. gondii; the brain was also used for DBL 
staining of tissue cysts. Blood was taken for Modified Agglutination Assay (MAT) (Dubey and 
Desmonts, 1987); the cutoff value was set at 1:25 (Dubey et al., 1995a and 1995b). 
For tissue DNA examination, brain, heart, and lungs were pooled and homogenized; DNA 
was extracted using DNeasy Blood and Tissue kit (Qiagen; Cat No. 69504). PCR targeting the18S 
ribosomal RNA (18S rRNA) gene was used for T. gondii detection (Silva et al., 2009). The primer 
pair Tg18s 58F/Tg18s 348R at a concentration of 50 µM were used for PCR amplification (Silva 
et al., 2009). The expected DNA fragments with a size of 290 base pairs (bp) was examined on a 
2% agarose gel.  
For brain tissue cyst examination, one quarter of the brain tissue was taken and 
homogenized by sequentially syringing through gauge 16 and 20 needles. The tissue homogenate 
was fixed and permeated in fixing/permeabilizing solution (6% formaldehyde, 0.2% TritonX-100 
in PBS) for 20 mins at 4°C. Cells were washed with 10% goat serum in PBS. DBL at 1:300 final 
concentration (10µl DBL in 3ml 10% goat serum) was used to stain brain tissue cysts for one hour 
at RT in the dark. After two washings in 10% goat serum, the cysts were resuspended in 2 ml PBS. 
Ten microliters of cysts in PBS was mounted onto a glass slide and examined for tissue cysts under 
a fluorescent microscope (Leica DMRX, Leica Microsystems).  
Results 
Detection of protein expression of vacuum treated TgCkVe6 via IFA 
Four days in a vacuum bag at room temperature (RT), the morphology of TgCkVe6 became 
unrecognizable, and parasites in PVs deformed and merged into dotted smudges. Recover slowly 
took place in 37 ℃, 5% CO2 incubator, and eventually after 7 -10 days, parasites formed large 
persisting cysts.  
The staining of BAG1 was indicated by the green fluorescence (Figure 5.1). The 
monoclonal rabbit anti-BAG1 antibodies (1:100) was used as primary antibody, and FITC-




In another independent experiment (Figure 5.2), CST1 was stained with FITC conjugated 
DBL (1:300). A significant number of cysts were stained as indicated by the green fluorescence 
(Figure 5.2). 
To compare the protein expression of treated TgCkVe6 and non-treated TgCkVe6, we 
simultaneously stained BAG1 and CST1 (Figure 5.3) of treated and non-treated parasites. The 
nuclei were also stained with DAPI. For BAG1 staining, the secondary antibodies Alexa Fluor 594 
goat anti-rabbit IgG at 1:100 was used. In Figure 5.3, the staining of BAG1 was observed in both 
treated and non-treated groups; however, CST1 expression was only observed in treated TgCkVe6. 
The cross-emission of FITC and DAPI was pronounced in Figure 5.3 as FITC emission extended 
to DAPI channel and vice versa.   
Acid-pepsin digestion of vacuumtreated TgCkVe6  
All TgCkVe6, vacuum treated and non-treated, succumbed after 30mins acid-pepsin digestion at 
37℃. Therefore, a shorter digestion period, namely 15 mins, was chosen for further testing. The 
results of the acid-pepsin digestion assay were summarized in Table 5.1. A small proportion 
(0.24%) of treated TgCkVe6 were pepsin resistant, whereas all non-treated parasites succumbed 
after 15min acid-pepsin digestion at 37℃. Results of a repeat testing of the pepsin resistance were 
summarized in Table 5.2. No pepsin resistant parasite was identified regardless of whether the 
conversion treatment was applied (Table 5.2). In addition, the survival rate (150%) for those kept 
in the 0.9% NaCl for 15 mins at 37℃ was rather implausible as it exceeded 100% (Table 5.2). The 
problem lay in the enumeration process. The incomplete disruption of tissue cysts likely skewed 
the initial enumeration via plaque assay; those tissue cysts later ruptured and released a larger 
number of parasites during incubation in 0.9% NaCl.  
Detection of protein expression of 31°C treated T263 via IFA 
T263 produced notable large, persistent cysts at 31°C six days post-infection (Figure 5.4). Staining 
was done on BAG1 and CST1. The staining protocol was described in 2.2. DAPI was not used due 
to cross-emission with FITC. Although both treated and non-treated T263 express a certain degree 
of BAG1, indicating spontaneous conversion in the case of non-treated T263 (Figure 5.5). 




cyst wall expression of 31°C treated T263 was done seven days post-infection (Figure 5.6). Two 
different doses of T263, namely 105 (Figure 5.6 A) and 104 (Figure 5.6 B), were used to infect 
HFFs in each well of a 6-well plate. As shown in Figure 5.6, the infection rate of panel A was 
much higher than that of panel B. The CST1 expression was observed but with less intensity of 
fluorescence (Figure 5.6 A and B) as compared to that of in vitro produced TgCkVe6 (Figure 5.2). 
Oral infectivity of 31°C treated T263  
The three groups of total 15 mice were observed on a daily basis for three weeks. One mouse to 
which 2.5 ×104 tachyzoites were orally fed suffered from pain (hunched back, dehydration) two 
days after infection and succumbed five days post infection. The cause of death is unclear but 
could be the accidential damage of stomach tissue during the oral inoculation. As a result, no tissue 
or blood sample was taken from this mouse. One mouse to which 2.5 ×104 LN preserved 
bradyzoites were fed showed symptoms 17 days post-infection and was euthanized with tissues 
and blood collected. The remaining 13 mice survived 21 days post-infection and were euthanized 
with blood and tissue samples obtained.  
T. gondii antibody detection in blood showed that two out of five mice infected with LN 
preserved bradyzoites were T. gondii antibody positive with a titer of 1:400 (Table 5.3). Two out 
of four mice infected with tachyzoites were seropositive for T. gondii with titers of no less than 
1:1600 and 1:3200, respectively (Table 5.3). No seropositive sample was identified in the group 
of mice infected with fresh in vitro produced bradyzoites.  
PCR detection of tissue DNA confirmed serological results. T. gondii DNA was amplified 
from the tissues of four seropositive mice (Figure 5.7).  
DBL staining of tissue cysts were consitent with serological and PCR results with the 
exception of LNB No.5. LNB No.5 was from a mouse that showed symptoms 17 days post-
infection and was euthanized. Tissue cysts appear in mouse brain tissue at around two weeks post-
infection (Cristina et al., 2008), and requires a couple of weeks to grow large enough to be clearly 
observed under microscope. This may explain why no tissue cysts were seen in LNB No.5. More 
tissue cysts were identified in 10µl of brain suspension (one-quarter of brain in 2 ml PBS) in LNB 




found in LNB No.1 in 10µl of brain suspension, whereas only two were found in Tachy No. 2 and 
one in Tachy No. 1.  
Discussion 
Vaccines to control T. gondii infection have been up to now unsuccessful. Immunizing 
intermediate hosts have at best limited benefits, and the fact that there is rarely any commerilazed 
vaccine available for intermediate hosts compounds the problem.  A cystless strain S48, the only 
commercialized vaccine thus far, has been used to vaccinate sheep to reduce neonatal mortality in 
New Zealand and Europe (Buxton et al., 1993). With limited propagation in sheep, this vaccine 
can protect animals against T. gondii induced abortion for up to 18 months with one dose (Buxton 
et al., 1993; Innes et al., 1995). Vaccine candidates for pigs have been tested to have promising 
outcomes in laboratory. RH strain, a non-persistent strain, has been shown to protect pigs and to 
prevent tissue cyst formation in pig tissues (Dubey et al., 1991). CpG Oligodeoxynucleotide has 
been used in conjunction with RH strain to enhance protective immunity in pigs (Kringel et al., 
2004). In addition, a DNA vaccine cocktail (GRA1-GRA7) had shown promises in eliciting strong 
humoral and Th1-mediated immune response in pigs (Jongert et al., 2008).  
A safe and effective vaccine for human use has not been developed. As T. gondii is an 
obligate intracellular parasite, the cell-mediated immune response induced by active parasite 
invasion is essential, which explains why vaccines using live parasites are necessary to stimulate 
protective immunity. However, live parasites pose a risk to human vaccine recipients as well as to 
those who handle vaccines. Obstacles and risks associated with human T. gondii vaccination 
highlight the importance of developing vaccine to immunize cats, its definitive hosts, to interrupt 
the human infection cycle.  
The mutant T263 demonstrated great promise in reducing T. gondii contamination by 
preventing cats from shedding oocyst (Mateus-Pinilla et al., 1999). Under laboratory conditions, 
one dose of T263 can prevent 84% of cats from shedding oocysts (Frenkel et al., 1991); two doses 
can prevent 100% of cats from shedding oocysts (Freyre et al., 1993). The corresponding numbers 
are lower, however, under field conditions. The seroconversion rate of cats in field experiment is 




The short shelf-life, demanding storage requirement, and cumbersome procedures for 
preparation hindered the application of vaccine T263. To simplify the vaccine production, an in 
vitro method to convert tachyzoite to bradyzoite is essential. It has been known that tachyzoite to 
bradyzoite conversion is a stress-related phenomenon. Conventionally, high temperature (43 ℃), 
high (8.0-8.2) or low (6.6-6.8) pH, chemical stresses (i.e., sodium arsenite) can induce tachyzoite 
to bradyzoite conversion (Soete et al., 1994). However, the use of these methods in our attempts 
caused host cells damage severe enough to render them unable to support parasites growth.  
We investigated two methods to convert T263 from tachyzoites to bradyzoites to bypass 
the mouse bioassay. We showed that vacuum conditions can successfully convert TgCkVe6 to 
bradyzoites. We fortuitously stumbled upon this method from attempts to develop a technique for 
shipping of cell cultures. Obstacles posed in cell culture shipping is that the media often become 
acid, which become detrimental to host cells and parasites. To maintain a neutral pH, we put the 
cell cutures (HFFs infected with TgCkVe6) into a vacuum bag with air depleted. The cell cultures 
in a vacuum bag was incubated at RT for four days to simulate the duration of shipping. To test 
the duration of recovery of the cell culture once delivered, we transferred the cell culture to 37 ℃, 
5% CO2 incubator. After seven to eight days, large persisting cysts were unexpectedly observed, 
which prompted us to utilize the vacuum for conversion.  
The in vitro produced TgCkVe6 bradyzoites expressed BAG1 and formed tissue cysts as 
evidencd by CST1 detection via IFA. Pepsin digestion assay showed that a small percentage of 
treated parasite TgCkVe6 were able to survive acid pepsin treatment for 15 min. However, the 
pepsin digestion assay was not repeatable as no resistant parasites were identified on repeat testing. 
It has been shown that the in vitro produced bradyzoites were acid-pepsin resistant (Dubey et al., 
1998; Popiel et al., 1996) and can orally infect both mice (Fux et al., 2007) and cats (Hoff et al., 
1977). The pepsin resistance rate of the in vitro alkaline-induced bradyzoite (9 days post-infection) 
ranges from 0.03% to 9.4%, depending on the strain (Fux et al., 2007). The discrepancy seen 
between our results and those in publications may be attributable to the preparation procedure and 
the different methods used to estimate bradyzoite numbers before pepsin digestion. In our 
experiment, in order to precisely measure the quantity of bradyzoites, we completely released 




studies, cysts were enumerated using hemocytometer under microscope, and the number of 
bradyzoites in cysts were roughly estimated as 10 to 20 bradyzoite per cyst (Fux et al., 2007).  
In contrast, when the vacuum was applied to T263, no large persisting cysts were formed. 
Instead, due to the harsh vacuum conditions, T263 disintegrated after treatment, leaving numerous 
empty vacuoles in host cells. The discrepancy seen between TgCkVe6 and T263 reflects T. gondii 
strain variation. A wide array of factors account for the observed discrepancy of conversion ability 
under vacuum conditions. It’s known that strains with a slower rate of replication and lower 
virulence are more likely to develop cysts in vitro (Matsukayashi et al., 1963; Weiss and Kim, 
2011). This holds true in the case of TgCkVe6 which is slow-growing and prone to form large 
vacuoles even at 37 ℃ with 5% CO2. 
Luckily, we also tested the temperature effect on the growth of T263, including high 
temperature at 43℃ and 41℃, low temperature at 33℃ and 31℃.  At 43℃, both host cells and 
T263 were unable to survive. At 41℃, parasites invade and lyse host cells as efficiently as those 
at 37℃. At 33℃, the growth of the parasite slowed down but not enough to form large persisting 
cysts. However, at 31℃, parasites were able to develop large persisting cysts. We used IFA and 
mouse bioassay to validate the conversion from tachyzoites to bradyzoites. Pepsin digestion was 
not conducted on this strain due to its inconsistency when used on vacuum-treated TgCkVe6. The 
expression of BAG1 and CST1 were evident in converted T263, indicating successful conversion. 
However, when compared to the vacuum-treated TgCkVe6, less CST1 expression was found in 
31℃ treated T263.  
Through oral infection of mice, we demonstrated that the LN preserved bradyzoites of 
T263 at a dose of 2 × 104 cysts were able to infect 40% (2/5) of mice and form a significant number 
(7 × 200 × 4 = 5,600) of tissue cysts in a mouse brain. This proved that our in vitro produced T263 
bradyzoites were infectious after four months of preservation in liquid nitrogen, indicating the 
feasibility of preserving in vitro produced bradyzoites in liquid nitrogen. Although two (2/4=50%) 
mice in the tachyzoite group were also infected, we found less tissue cysts (1,600 or 800) in their 
brains. This preliminarily suggests that our in vitro produced T263 bradyzoites are more prone to 
form tissue cysts in mice. Dubey has shown that the number of bradyzoites required to orally infect 
a mouse is 1000, whereas the corresponding figure for tachyzoite is >106 (Dubey, 1998). In our 




between Dubey’s results and ours indicates strain variation. Fux et al. have shown that 1000 pepsin 
resistant bradyzoite were able to infect 50% of mice (Fux et al., 2007). In our study, we presumably 
used much more than 1,000 bradyzoites as one cyst contains more than one bradyzoite. It is 
possible that the conversion rate in our study is low resulting in few mature bradyzoites in each 
tissue cysts. Alternatively, we have used a much higher dose of bradyzoites in mice infection. 
Further study should increase the conversion efficiency using 31℃. To increase the conversion 
efficiency, no more than two passages of T263 at 37 ℃ after revived from liquid nitrogen should 
be allowed before the conversion treatment. Observation has been made that frequent passage of 
T263 37 ℃ resulted in difficulties in conversion. The growth of T263 could not be easily slowed 
down by the sole treatment of 31℃ once parasites were in burgeoning state.  
Counterintuitively, our freshly prepared T263 bradyzoites failed to infect mice.  The 
problem lay in the inadequate number of mature bradyzoites fed to each mouse. Although the same 
number of parasites (6 × 105 to 8 × 105 parasites) were initially used to infect HFFs in a T25 flask, 
these parasites were not in their most active state at the time of infection. CO2 supply was briefly 
disrupted during the course of the treatment. Cell culture likely experienced a shock due to CO2 
outage, which may account for the compromised growth of the parasites.  
The signaling pathways and the molecular mechanisms of interconversion are unknown. 
However, as a stress-induced response, the common stress-related pathways in eukaryotic 
organisms are implicated. Cyclic nucleotide kinase is believed to partly mediate the differentiation 
(Eaton et al., 2006). A study has determined that inhibition of cAMP-dependent kinase and cGMP-
dependent kinase reduced parasite replication and induced differentiation (Eaton et al., 2006). 
Parasite-specific eukaryotic initiation factor-2 (eIF2) kinase was also implicated in the 
differentiation process (Sullivan et al., 2004). As both protein chaperones and regulators of 
transcription, the heat shock proteins (HSPs) induced during stress response have gained 
significant research interests. After alkaline stress at pH 8.1, hsp70 was induced three to four folds 
more than that of at pH 7.1, consistent with the induction seen in other Apicomplexans (Weiss et 
al., 1998; Shiels et al., 1997). Inhibition of HSPs synthesis using quercetin hindered the in vitro 
bradyzoite development (Weiss et al., 1998).  
The molecular mechanisms underlying the induced conversion using vacuum and 31 ℃ are 




O2, and low temperature at RT, for both the host and the parasite. Temperature change has been 
known to induce differentiation. Heat shock (43℃) host cells for two hours with or without heat 
shock of infected cells for 12-48 h has been used for bradyzoite differentiation (Skariah et al., 
2010). Low temperature (RT or 31 ℃) likely reduces the growth rate of both host cells and 
parasites, which contributes to the conversion (Weilhammer et al., 2012). 
Secondly, hypoxia likely alters host and parasite metabolisms and contributed to the 
conversion. The hypoxia-inducible transcription factor (HIF-1 α), a transcription factor that is 
activated by hypoxia, is likely activated under vacuum conditions. HIF-1α is critical in preserving 
the health of both host cells and parasites, especially under hypoxia. It has been shown that HIF-
1α and its downstream signaling pathways (glycolysis, growth-factor signaling, and angiogenesis) 
were upregulated in T. gondii infected fibroblasts (Gail et al., 2001; Blader et al., 2001). In 
addition, HIF-1α also plays an essential role in T. gondii growth and organelle maintenance at 3% 
oxygen (Spear et al., 2006).  
Lastly, low CO2 may also be a trigger of conversion under vacuum conditions. Previously, 
low CO2 (0.03%) has been used to induce tachyzoites to bradyzoites conversion (Bohne and Roos, 
1997). Depleting of CO2 or low CO2 was thought to cause pyrimidine starvation as CO2 is the 
substrate for de novo pyrimidine biosynthesis.  
The successful development and large-scale application of a cat vaccine based on T263 are 
only possible when the obstacles involved in vaccine production are overcame, among which is 
the cumbersome, time-consuming, and expensive procedure for bradyzoite production. Our study 
identified a new technique to produce bradyzoites in vitro. Further refinement of the technique, 
followed by tests in cats, is needed to validate the efficacy of the method. In particular, it’s 
imperative to test whether the in vitro produced T263 bradyzoite can induce protective immunity 
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Chapter 5 Appendix 
 
                                                                                    400 × 
Figure 5. 1 The examination of BAG1 expression of T. gondii TgCkVe6 using IFA. TgCkVe6 
was vacuum treated as described in 2.1. Seven days post incubation at 37 ℃, 5% CO2, TgCkVe6 
formed large persisting cysts under bright light microscope. The primary antibody, monoclonal 
anti-BAG1 antibodies (1:100), was added and incubated at 4℃ overnight. The next day, FITC-
conjugated goat anti-rabbit IgG (1:100) were added as secondary antibodies. Fluorescent 
microscope (Leica) was used for observation at 1000×. The green fluorescence indicated the 
expression of BAG1 on parasite surface. The above image illustrates two large adjacent tissue 








                                                                                                     400 × 
Figure 5. 2 The examination of CST1 expression of T. gondii TgCkVe6 using IFA. TgCkVe6 
was vacuum treated as described in 2.1. Seven days post incubation at 37 ℃ 5% CO2, TgCkVe6 
formed big persisting cysts. The FITC conjugated DBL (1:300) was used to stain CST1 for one 
hour at RT. Fluorescent microscope (Leica) was used for observation at 400×. The above image 
indicates the expression of CST1 on cyst wall surface in green. The overlapping area of two tissue 









Figure 5. 3 Simultaneous examination of BAG1 and CST1 in treated or non-treated T. gondii 
TgCkVe6 using IFA. The monoclonal rabbit anti-BAG1 antibodies (1:100) was used as primary 
antibodies, and secondary antibodies were Alexa Fluor 594 goat anti-rabbit IgG at 1:100. Upon 
washing, FITC-conjugated DBL at 1:300 was added for CST1 staining at RT for one hour. Nuclei 
were also stained with DAPI for five minutes at RT. Fluorescent microscope (Leica) was used for 
observation at 400×. The expression of BAG1 was indicated in green fluorescence, whereas the 
expression of CST1 was shown in red fluorescence. The staining of nuclei was in blue. The cross-




















                                                                                                       400 × 
Figure 5. 4 The large vacuoles of T263 at six days post-infection at 31 °C. T263 was allowed 
to infect HFFs at 31 °C and kept at 31 °C 5% CO2 incubator for seven to eight days. The big 

















                                                                                                               400 × 
Figure 5. 5 Simultaneous staining of BAG1 and CST1 of T263 (six days post-infection at 31 
°C) using IFA. T263 was allowed to infect HFFs at 31 °C and kept at 31 °C, 5% CO2 incubator 
for six days. The monoclonal rabbit anti-BAG1 antibodies (1:100) and Alexa Fluor 594 goat anti-
rabbit IgG (1:100) were used as primary and secondary antibodies, respectively. FITC-conjugated 










                                                                                              400 × 
Figure 5. 6 DBL staining of T263 seven days post-infection at 31°C using IFA. A) 3 ×105 T263 
tachyzoites were used to infect HFFs in each well of a 6-well plate. FITC-conjugated DBL at 1:400 
was added for CST1 staining; B) 3 × 104 T263 tachyzoites were inoculated into each well of a 6-














Figure 5. 7 PCR detection of T. gondii DNA from tissues of experimentally infected mice. A) 
Two out of five mice (LNB No.1–No.5) infected with liquid nitrogen preserved bradyzoites (LNB) 
were positive for T. gondii in their tissues (heart, brain, and lungs); two out of four mice (Tachy 
No. 1–No.4) that were infected with fresh tachys were positive for T. gondii in their tissues (heart, 
brain, and lungs). No positive sample was detected in a group of five mice (FB No.1–No.5) 
infected with fresh bradyzoites (FB); GT1 was a T. gondii strain used as positive control. N denotes 
negative control in which DNA was not added. B) A paralle repilcate of panle A. PCR was done 







                                                                                                      400 × 
Figure 5. 8 DBL staining of brain tissuse cysts. A quarter of brain tissue was homogenized and 
stained with FITC-conjugated DBL. A total of three positive samples were identified, namely LNB 
No.1, Tachy No.2, and Tachy No.1. Seven cysts were found on a glass slide with 10µl of brain 
suspension in LNB No. 1, whereas two were found in Tachy No. 2, and one was found in Tachy 
No.1. A) Two cysts were shown from sample LNB No.1 which was from a mouse that were orally 
infected with liquid nitrogen preserved bradyzoites; B) One image from Tachy No. 1 which was 
obtained from a mouse that was orally infected with in vitro produced fresh tazhyoites. C) One 







































 Initial  After treatment Survival rate 
0.9% NaCl, 15 mins 5 x 10 5 1.36 x 10 5 27 % 
Pepsin, 15 mins 5 x 10 5 1.2 x 10 3 0.24 % 
Non-treated parasites 
 
 Initial  After treatment Survival rate 
0.9% NaCl, 15 mins 2.05 x 10 5 1.52 x 10 5 74 % 









 Initial  After treatment Survival rate 
0.9% NaCl, 15 min 2.25 x 10 4 2.24 x 10 4 99.6 % 
Pepsin, 15 min 2.25 x 10 4 0 0 % 
Non-treated parasites 
 
 Initial  After treatment Survival rate 
0.9% NaCl, 15 min 8 x 10 4 1.2 x 10 5 150 % 
















<25 25 50 100 200 400 800 >=1600 >=3200 
LNBa  5 3 0 0 0 0 2 0 0 0 40% (2/5) 
Tachysb 4 2 0 0 0 0 0 0 1 1 50% (2/4) 
Fresh 
bradysc 5 5 0 0 0 0 0 0 0 0 0 
 
aA group of five mice were orally infected with liquid nitrogen preserved bradyzoites (LNB);  
bA group of five mice were orally infected with in vitro produced fresh tachys; one mouse died  
due to accidental puncture of lung whose carcass was simply discarded without collecting samples. 































































The research conducted in this dissertation represents four of the many aspects of current T. gondii 
study. My first project continued the interest of our lab and investigated the genetic structure of T. 
gondii in North America. We were able to summarize the genotyping data generated in the past 
decade and examine the underlying factors in shaping the population structure of T. gondii in North 
America. My second project aimed to evaluate the environmental contamination by T. gondii on a 
farm with cats. The evaluation of environmental contamination is fundamental to the development 
of control measures to reduce T. gondii infection in humans and animals. My third project focused 
on the isolation and characterization of T. gondii from clinal fatal toxoplasmosis from macropods. 
T. gondii infection in captive macropods continues to be a problem as zoos and theme parks suffer 
from the enormous economic loss. In my last project, I strived to convert tachyzoites to bradyzoites 
in vitro in hope to simplify the preparation of a cat vaccine T263 to reduce its costs.  
Investigating factors shaping T. gondii genotype landscape in North America 
Our lab has been interested in the population genetics of T. gondii. The genotypes of T. gondii 
were defined by the multilocus PCR-RFLP genetic markers; the method was initiated by Howe 
and Sibley (Howe and Sibley, 1995) and refined later (Su et al., 2006 and 2010). Our lab has 
worked to expand the application of multilocus PCR-RFLP to make data comparable across labs 
worldwide. With the extensive use of this methodology, a collection of 1400 samples from across 
the world has been genotyped by 2014 (Shwab et al., 2014). The genetic structure of T. gondii was 
revealed on a global level. My first project built upon the publication of Shwab et al. in 2014 and 
focused on the genotype landscape in North America. I particularly researched the human 
influence on T. gondii genotype distribution, and whether T. gondii genotype had host species 
specificity. We concluded that T. gondii genotype diversity and the host proximity to human 
settlement had an inverse relationship. Moreover, the dominant genotypes in groups of animals 
with different association with human activities were different. Type II and type III were found 
predominant in farm-bound animals, whereas type 12 dominated in wildlife. The dominant 
genotypes in farm-bound animals (Type II and III) and that in wildlife (Type 12) were found almost 




human influence on T. gondii transmission. A between-population comparison was conducted to 
study the effect of host specificity on T. gondii genotype distribution. Fourteen populations based 
on animal species with more than ten isolates were selected. The significant differences were found 
between certain animal populations, indicating that host specificity affected T. gondii genetic 
structure. In the future, more samples from the definitive host especially cats and bobcats, are 
necessary to understand the transmission dynamics of T. gondii in the environment.  
The assessment of T. gondii environmental contamination on a dairy farm 
This body of research aimed to develop a feasible method to evaluate environmental contamination 
by T. gondii. A typical farm affiliated with the University of Tennessee at Knoxville was chosen 
to perform the research. We affirmed that the soil oocyst contamination is marginal to the 
sensitivity of the current detection system. The sugar floating method (Lelu et al., 2011) in 
conjunction with PCR-RFLP following DNA extraction method (Silva et al., 2009) was used in 
our study. As we are aware of the potential loss of oocyst during the process of DNA extraction, 
we made attempts to skip the DNA extraction process. However, when DNA extraction was 
omitted, issues arose from PCR contamination or PCR inhibition by soil substances (e.g., humic 
acid). The low concentration of oocyst in soil is likely due to a few factors. First, the massive 
nature of soil dictates that oocysts excreted by cats will be extremely diluted in the soil. In addition, 
the unpredictable, harsh environmental conditions, such as desiccation and radiation from sunlight, 
likely disintegrated oocyst over time. Above all, soil oocyst DNA detection offered no information 
concerning the viability of oocyst, and thus bore little or no implicative values to the infection in 
animals and humans. Therefore, results generated based on soil oocyst detection may be difficult 
to interprete due to potential contamination.  In summary, soil oocyst detection may not be a 
suitable parameter for future contamination evaluation. 
The focus of the research then switched to the evaluation of infection in farm animals, both 
domestic and wildlife. Our study herein demonstrated that rodents had low infection rate. 
However, a partition of rodent habitats was discovered as human household associated house mice 
were geographically captured away from those of wild rodents. This supports the idea of two 
geographically separated T. gondii transmission cycles, namely the domestic cycle and the sylvatic 




particularly have higher T. gondii infection and thus are better targets for contamination 
assessment. The field trapping data had revealed that opossums were easy to trap and had high 
recapture rate and thus would be a good target for assessment. However, the serological results 
from opossums showed that they are all negative for T. gondii antibodies. It was hard to 
comprehend as to the reasons behind the negative results although plausible speculations were 
raised. Further study to isolate parasites from opossums could hopefully unravel the mystery. 
In conclusion, our current study suggested that future evaluation of T. gondii environmental 
contamination should target animals in the higher trophic level instead of focusing on detecting 
soil oocyst and rodent infection.  
The investigation of eleven fatal toxoplasmosis cases in captive macropods 
Fatal toxoplasmosis occurred in 11 captive macropods in a theme park in Tampa, Florida. The 11 
macropods successively succumbed to T. gondii infection over four years from 2014 to 2017. 
Infection was confirmed via serology, histopathology, parasite isolation as well as PCR-RFLP 
genotyping. Genotyping of these parasites either directly from animal tissues or from isolated 
parasites revealed three genotypes, #2, #216 and #263. Notably, animals died in the same month 
had the identical genotypes, suggesting that these animals were infected during the same 
transmission event.  The three disdinct genotypes indicate that at least three distinct transmission 
events were responsible for these intermittent incidences.  
Macropods are among the most susceptible hosts of T. gondii. The infection of macropods 
in the wild is unknown as there are no wild macropods in the USA. Of the ten wallabies imported 
from New Zealand, nine wallabies succumbed to acute T. gondii infection at a zoological facility 
in Virginia, USA (Guthrie et al., 2017). Two genotypes were revealed, namely #4 (n=3) and #263 
(n=6). The study presented herein reinforced the high mortality of acute toxoplasmosis in these 
susceptible animals and accentuated oocyst-mediated transmission. It was suspected that the 
seasonal heavy rainfall in the theme park likely washed oocyst down to the animal exhibit. The 
exact source of infection has not been investigated. Further study to isolate oocyst from exhibit 
soil for mice bioassay is likely helpful to identify the source of infection. In addition, the isolation 




identificating of infection source. This study also highlights the urgency of control measures to 
reduce T. gondii contamination in zoos and theme parks with the presence of macropods.  
The in vitro conversion of T263 from tachyzoite to bradyzoite 
In this chapter, we attempted to develop a conversion approach to produce cat vaccine T263 in 
vitro in hope to simplify the vaccine preparation and thus reduce its cost. The strategies we tested 
included vacuum conditions and low temperature at 31°C. To evaluate the quality of treated 
parasites, we used three assays, namely IFA, pepsin digestion, and mice oral infection. We 
concluded that vacuum conditions were able to convert TgCkVe6 from tachyzoites to bradyzoites 
but was unable to convert T263. Vacuum treated TgCkVe6 expressed BAG1 and CST1; our first 
test showed that a small percentage (0.24%) of vacuum treated TgCkVe6 were pepsin resistant, 
although the results were not reproductive. Low temperate at 31 °C was able to convert T263 from 
tachyzoites to bradyzoites. The expression of BAG1 and CST1 were observed in converted T263. 
However, the cyst walls were less intensely stained when compared to those of converted 
TgCkVe6. The converted bradyzoites T263 were able to orally infect mice which demonstrate 
promise for using this approach to produce T263 vaccine in vitro. Although preserved in liquid 
nitrogen for four months, parasites at a dose of 2.5 ×104 cysts were still viable and infectious to 
mice. The counterintuitive results were observed in freshly prepared bradyzoites. The explanation 
was that the initial infection rate is low, which resulted in an inadequate number of mature 
bradyzoites. A short period of CO2 outage likely adversely affected the development of 
bradyzoites. Further studies should aim to optimize the protocol to minimize between-batch 
inconsistency. A repeat of mice orally infection assay is required to further evaluate in vitro 
produced T263 bradyzoites. Finally, a bioassay in cats is necessary to test the efficacy of the in 
vitro generated T263 as a vaccine to induce immunity to oocyst shedding. 
Future directions 
The overarching objective of our current research to break the infection cycle of T. gondii to reduce 
infection rates in humans and animals. To accomplish this, much more information of the nature 
of T. gondii distribution and transmission is needed. Our contribution to this overarching effort 




study to estimate a more accurate animal home range is needed for a more precise classification of 
animals into the aforementioned three categories. With the understanding of T. gondii transmission 
and genetic diversity, we assessed the farm contaminant of T. gondii in attempt to establish the 
baseline for contamination. Future study on a pig farm with more concentrated cats is needed to 
elucidate the contamination rates in both soil and animals. For that purpose, the home range of 
meso-predators need to be determined to ensure their sole association with the study farm. It’s also 
imperative to re-assess the soil contamination of T. gondii, especially in areas where the presence 
of cats is frequent. In addition, we developed a method to simplify a cat vaccine production. Future 
study should focus on increasing the efficiency of tachyzoites to bradyzoites conversion of T263 
to increase mice infection rate. Moreover, the oral infectivity of in vitro produced bradyzoites T263 
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1. 4% formaldehyde 
2. Permeabilizing buffer: 0.5% triton: 50 µl triton in 9950 µl PBS 
 
                                                                                     1g of BSA powder  
3. Blocking buffer: 0.1% triton & 10% BSA in PBS       10 µl triton (× 100) 
                                                                                                  9990µl PBS 
4. BAG1 antibodies (1:100): 50 µl BAG1 in 5ml blocking buffer 
5. Alexa Fluor 594 conjugated goat anti-rabbit IgG (1:100): 60 µl Alexa Fluro 5945 in 6 ml 
blocking buffer   






1. Remove medium and wash cells with ice-cold PBS for three times 
2. Add 1ml 4% formaldehyde into each well of a 6-well plate; incubate at RT for 30 min. 
3. Wash with ice-cold PBS for three times 
4. Permeate cells by adding 1ml of permeabilizing buffer into each well; incubate at RT for 
20 min.  
5. Wash with ice-cold PBS for three times. 
6. Add blocking buffer (1ml for each well); incubate at 37 °C for 1 hour 
7. Remove blocking buffer but no need for washing; add BAG1 antibodies (1:100) and 
incubate at 4°C overnight. 




9. Add secondary antibodies (Alexa Fluor 594 anti-rabbit IgG) at 1:100; incubate at RT for 1 
hour. 
10. Wash with blocking buffer for three times 
11. In each well, add 1ml DBL at 1:300 into each well and incubate for 45 min to 1 hour. 
12. wash three times with blocking buffer 





























1. One T25 flask of HFFs infected with treated parasites; another one with non-treated 
parasites 
2. 0.17 M NaCl (pH=7) 
3. Syringes 
4. HFFs confluent in 12-well plates 
5. 0.26 mg/ml pepsin in 0.17M NaCl (pH=1.4) 
6. 1.2% sodium bicarbonate (pH=8.3) 
7. 70% ethanol 
8. pH paper 




1. Take a T25 flask of HFFs infected with either tachyzoites or in vitro produced bradyzoites; 
transfer parasites into one 50-ml tube and spin down at 1500 rpm for 10 min. 
2. Remove supernatant and resuspend parasites in 5 ml PBS. Syringe parasites through a 22-
guage needle for four times to release parasites from PVs or host cells. 
3. Enumerate viable parasites by inoculating parasites into confluent HFFs in a 12-well plate. 
To do that, make a ten times serial dilution (10-1 to 10-4) of the cell suspension. Inoculate 
100 µl of diluted parasites at each concentration into each well of a 12-well plate.  
4. Equally split parasites from one T25 into two 15-ml tubes: one will be subjected to pepsin 
digestion; one will be negative control. 
5. Spin down parasites to remove supernatant. Add 5ml 0.26 mg/ml pepsin in 0.170 M NaCl 
(pH=1.4) into one tube and add 5ml PBS into the other tube. Incubate for 30 min at 37°C. 
6. Neutralize with 1.2% sodium bicarbonate (pH=8.3). Spin down to remove supernatant. 




8. Change media of the 12-well plates the next day and incubate for seven days at 37°C in 
5% CO2 incubator.  
































Appendix C: Mouse Bioassay of 31 °C Treated T263  
 
Reagents:  
1. HFFs in T25 flasks 
2. T263 tachyzoites grown in HFFs 
3. 15 outbred female mice (CD1) for three treatments (five per treatment) 
4. Feeding tubes, 3cc syringes, marker 
5. PBS 
Procedure: 
1. Infect two sets of three T25 flasks of HFFs with approximately 6-8 × 106 T263 tachyzoites 
grown at 37 °C.  
2. Place one set of three flasks into 31 °C, 5% CO2 incubator and culture for 7 to 8 days. For 
the other set of three flasks of T263, keep at 37°C, 5% CO2 and passage every two days.  
3. After 7 to 8 days, in 31°C treated cell culture, cysts (PVs) should be visible under 
microscope, take pictures of treated T263. 
4. Preserved two T25 flasks into four cryovials in liquid nitrogen (LN): scrape cells off from 
each flask and collect cell suspension into a 15 ml tube. Spin down cells at 1800 rpm for 
10 mins; remove the supernatant and add 1ml DMEM with 50% FBS to resuspend the 
pellet, then add 1ml 20% DMSO in DMEM. Aliquot into two cryovials for each T25 flask 
and put in a box with dry ice. The next day, transfer into LN.  These are cryopreserved in 
vitro produced bradyzoites. 
5. For fresh 31°C treated cell culture, 7 to 8 days post infection, scrape cells from three flasks. 
Combine, wash, and resuspend in 5 ml PBS. Count cells (a mixed population of HFF cells 
with or without PVs enclosed) using hemocytometer.  These are fresh in vitro produced 
bradyzoites. Prepare 2.5 ×104 cysts/ml in 5ml PBS for a group of 5 mice. 
6. The non-treated cell culture is passed every two days at 37 °C; Collect cell suspension and 
syringe through a 22-guage needle to completely separate host cells from tachyzoites. 




a group of 5 mice. It’s reported that at least 106 tachyzoites were required to infect a mouse 
(Dubey, 1998). 
7. Four vials of LN preserved in vitro produced bradyzoites are thawed at 37 °C in water bath. 
Wash and resuspend in 5ml PBS. Enumerate parasites using hemocytometer.  Prepare 2.5 
×104 cysts/ml in 5ml PBS for a group of 5 mice. Based on published paper, 1000 mature 
bradyzoites are required to infect a mouse (Fux et al., 2007).  
8. Three groups of five mice are orally infected with three treatments (fresh tachyzoites, LN 
preserved in vitro produced bradyzoites, and fresh in vitro produced bradyzoites) (1ml for 
each mouse). Be sure to ease the feeding tube (the end tip of the feeding tube facing toward 
the experimenter) into mouse digestive tube and deliver all the way down to mouse 
stomach. Be careful not to puncture lung as doing so will cause immediate death of the 
mouse.   
9. Monitor for three weeks. The survivors are euthanized. Blood samples are taken for MAT; 
brain, heart, and lung tissues are taken for PCR detection and cyst examination. 
10. For cyst examination, FITC-conjugated DBL is used to stain brain homogenate. 
Fluorescent microscope is used to examine cyst wall staining with DBL. Refer to DBL 
staining for detailed procedure.  
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Appendix D: Staining Toxo Cysts in Brain Lysates by FITC-conjugated DBL 
 
Reagents:  
1. Fixing and Permeabilizing solution- 6% formaldehyde, 0.2% trition- ×100 in PBS.  
                                               H2O                              3 
                                               10 × PBS                      1 
                                               10% formaldehyde       6 
                                               Triton-x 100            0.02 ml  
                                               Total                          10 ml 
2. 10% goat serum in PBS 
                                               H2O                              40 
                                               10 × PBS                      5 
                                               Goat serum                   5 ml 
                                                     Total                           10 ml 
 
3. FITC-conjugated DBL (Vector) stock solution (1:3 in PBS) 
Procedure: 
1. Prepare brain suspension in 2ml PBS by syringe pass through gauge 16 and 20 needles. 
2. Add 1ml brain lysate to 1ml fixing and permeabilizing solution using a 15 ml polystyrene 
centrifuge tube. Incubate for 20 min at 4 °C. 
3. Spin for 10min at 1700 rpm in TC centrifuge at 4 °C. 
4. Wash once with 4ml PBS/10% goat serum. Spin down tissue cysts and remove supernatant. 
5. Add 2 ml 10% goat serum in PBS, 20 µl FITC-conjugated lectin stock solution (final 
concentration is 1:300; 1: 1000 is okay too!) for 45 min to 1 hour. 




7. Resuspend cysts in 2ml PBS. 
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